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ABSTRACT
As a key evolutionary process, recombination shapes the genetic structure of virus
populations. The increased availability of virus sequences provides a chance to study virus
recombination through molecular data. Many statistical methods have been developed,
and a lot of the methods are phylogenetic-based. My research focuses on recombination
modeling and data analysis.
I first apply an existing phylogenetic-base method, Bayesian dual change-point model
(DMCP), to investigate the role of representative data types for recombination study.
We conclude that consensus sequences are an all-around robust representative of virus
genotypes. Using consensus data we study recombination of all full-length hepatitis B
virus (HBV) sequences, and setting up a system for using the DMCP model for large
scale sequence analysis. We discover that HBV has an extremely high recombination
rate. For the first time, we report circulating recombination forms of hepatitis B virus,
and identify one potential recombination hotspot.
One goal of studying recombination is to find potential recombination hotspots, which
could ultimately reveal information about the molecular mechanism of recombination.
Finding hotspots requires unambiguous identification of all unique recombination events,
a non-trivial task when recombination sequences have similar mosaic structures. Extend-
ing the DMCP model, I develop a method to identify the number of recombination events
producing multiple recombinants. I apply this method to several HBV recombinants with
identical mosaic structure and find at least two recombinant events.
1CHAPTER 1 INTRODUCTION
Many human pathogenic viruses such as human immunodeficiency virus (HIV), and
hepatitis B virus (HBV) display significant sequence heterogeneity. The different variants
of a high diversity virus can be classified into multiple groups, called genotypes, based on
geographic and phylogenetic analysis. Clinical evidence shows that genotypes might be
related to disease pathogenesis. In addition, many high diverse viruses have been found
to be recombinogenic. Genetic recombination, the formation of chimeric molecules, is one
of the most important mechanisms to generate novel genomes that may have selective
advantages over parental genomes. Previous studies have indicated that recombination is
related to several important medical concerns of viruses such as virulence (Liitsola et al.
1998), drug resistance (Kellam et al. 1995), vaccine development (Korber et al. 2001),
and probably virus co-species transmission (Rest et al. 2003). It is important to be able
to classify viruses into correct genotypes and to study the mechanism of recombination
on a molecular level.
Many wet lab experiments have studied viral recombination. There is solid evidence
for the occurrence of virus recombination. In vitro and vivo studies have revealed var-
ious recombination frequencies along the genome for some viruses such as HIV (Dykes
2004, Zhuang 2002). Recombination rate variation could indicate the existence of re-
combination hotspots. It is hypothesized that recombination hotspots might be related
to specific primary sequences or RNA secondary structures (Balakrishnan 2001, Kohli
1999, Moumen 2001, Galetto 2004). Identifying recombination-associated sequences or
structures may reveal the molecular mechanism of recombination. While experimental
2data accumulates slowly, there is a growing amount of virus sequence data that can be
used to study natural recombination retrospectively. By estimating recombination rates
along the virus genome we might be able to elucidate the molecular mechanisms involved
in recombination.
Many computational methods for genotyping and recombination identification are
currently available. All recombination detection methods can be classified into phylo-
genetic methods, distance methods, compatibility methods, and substitution methods
(Posada 2002). Most methods can infer the occurrence of the recombination and usually
estimate parental genotypes. Only a few methods are able to estimate crossover points.
Most methods fall into a common statistical trap by using the same data to estimate
recombination and test the hypothesis. A Bayesian frame work has been introduced to
study recombination (Suchard 2002). This phylogenetic based method can avoid the
sequential testing trap by simultaneously inferring and testing recombination for a single
putative recombinant sequences. The method also provides accurate estimation of the
parental genotypes and the locations of cross over points (COP).
My research projects are based on the Bayesian dual change points (DMCP) recom-
bination detection‘model. Starting from chapter 2, I first introduce the basic concept
of genetic information. It is followed by a few sections reviewing molecular evolution,
phylogenetic reconstruction, evolution modeling, and the detail of Bayesian evolutionary
modeling. Chapters 3, 4, and 5 are research projects about virus recombination. One
of the limitations of phylogenetic-based methods for phylogeny inference is the com-
putational difficulty. As the number of sequences in the data increases the number of
possible topologies increase dramatically, which might cause difficulties to infer the cor-
rect phylogeny. The taxa-sampling method has been introduced to reduce the number
of sequences in the analyzed data. In chapter 3 I investigate the role of representative
data type in recombination detection. I first introduce 3 new taxa-sampling methods,
and then compare the performance of different taxa-sampling methods on recombination
3detection applying the DMCP model. In chapter 3 we identify the most efficient and
reliable taxon-sampling method for recombination detection. In chapter 4 I continue a
large scale study of genotyping and recombination detection on full length hepatitis B
virus sequences. One of the goals of the HBV study is to identify potential recombi-
nation hotspots. The result of HBV and HIV recombination study reveals that many
recombinant sequences of high diversity viruses share the same mosaic structures. It is
not clear that if these sequences were offsprings of a single recombinant sequence or were
generated by different recombination events. Therefore recombination hotspots identifi-
cation depends on a good statistical method to estimate recombination events from the
recombinants with similar mosaic structures. Currently there is no such model available.
Therefore, in chapter 5 I introduce a Bayesian multiple recombination event identifica-
tion model (MREM). The performance of the MREM model is tested in simulation. Also
we applied the MREM model to 6 HBV CB recombinants with identical recombination
structures and identify at least 2 past recombination events. Finally in chapter 6, I briefly
introduce a few future research projects.
4CHAPTER 2 REVIEW
2.1 Genetic information
The genome comprises the complete genetic information of a living organism, and
is passed to the next generation during reproduction. Although life is complicated and
highly diverse, the composition of the genome in all organisms is similar. In most organ-
isms the genome is the polymer deoxyribonucleic acid (DNA), whereas in some viruses it
can be ribonucleic acid (RNA). The monomer for both DNA and RNA strands is called
a nucleotide which consists of a phosphate group, a sugar molecule, and an organic base.
The sugar used for DNA is deoxyribose and for RNA is ribose. The bases in DNA are the
purines, adenine (A) or guanine (G), and the pyrimidines, thymine (T) or cytosine (C).
In RNA, thymine is replaced by the pyrimidine uracil (U). During polymerization, phos-
phodiester bonds link the 5’ carbon with the 3’ carbon between sugars to form a DNA or
RNA single strand. Since the linked nucleotides only differ in the bases, DNA/RNA can
be described as an ordered sequence of A, C, G, and T/U from the first 5′ to the last 3′
carbon. Strong triple hydrogen bonds between G and C and weak double bonds between
A and T bind two complementary DNA strands into a double helix structure. RNA
is single-stranded. During DNA duplication or RNA transcription, the DNA 3′− > 5′
strand is used by DNA/RNA polymerase to synthesize a new 5′− > 3′ strand. Due
to the efficient error detection and repair mechanism, the genetic information is mostly
preserved following DNA duplication and RNA transcription.
Random change occurs during DNA/RNA replication due to the occasional failure of
the error detection and repair mechanism. The random change is called genetic mutation.
5Genetic changes can be single nucleotide substitution, nucleotide insertion/deletion, or
recombination. Insertion/deletion is the gain or loss of one or more nucleotides. There is
another type of mutation, gene duplication, which is doubling a section of the genome.
Gene duplication has been found to happen repeatedly during the evolution of eukary-
otes, and it is considered as a special type of insertion in my thesis. Recombination
rearranges the genome by exchanging segments of DNA molecules. Mutations in body
cells can accumulate throughout a lifetime without being passed to the offspring. How-
ever, mutations in gametic cells can be passed to offspring and may accumulate along a
chain of descendants.
The mutation frequency varies for different species or genes. For example, the esti-
mated mutation rate for the six billion nucleotides of the diploid human genome is less
than one mutation per genome per cell division (Smith 2002). This rate is about one
hundred thousand times lower than the rate of HIV. The consequence of mutation can
be different for different species because of variable genome lengths and the proportion
of coding regions. For example most mutations in the human genome have little conse-
quence since only 10% of the human genome codes for proteins, though by chance some
very rare mutations can lead to severe genetic disease. Correspondingly, mutations are
more likely to have some effect for viruses such as hepatitis B virus due to the small
genome and the fact that there is no noncoding region for the HBV genome. The high
mutation rate of viruses can produce many non functional strains. At the same time
mutations can provide viruses a chance to escape attack from the immune system and to
generate new drug resistant strains.
2.2 Virus recombination
2.2.1 Introduction of virus recombination
Many viruses, especially RNA viruses, have spectacular diversity due to lack of proof-
reading ability of RNA-dependent RNA polymerase. Recombination also plays an im-
6portant role in virus evolution. For RNA viruses there are two distinct but not exclusive
recombinogenic mechanisms, genetic reassortment and recombination. Reassortment oc-
curs only in the viruses having segmented genomes. Reassortment swaps one or more
discrete RNA molecules between genetically related viruses. Antigenic shift in influenza
A virus is an example of this sort genetic exchange (Schlotissek et al. 1978, Gething et
1980, Kawaoka et al. 1989 ). It has been noticed that some segmented (multipartite)
viruses can experience recombination, sometimes even more frequently (Suzuki 1998, Si-
bold 1999, Greene 1994, Rott 1991) than nonmultipartite viruses. Recombination inserts
fragments of genes into a new virus strain from another genome. Compared to reas-
sortment, virus recombination forms chimeric molecules by rearranging genomes among
homologous or heterologous virus strains (Nagy 1997). Study of virus evolution has re-
vealed that recombination is a widespread phenomenon that has shaped modern viruses
(Worobey 1999b). Recombination can occur with high frequencies in all retroviruses, and
some DNA viruses (Umene 1999, Fang 2005).
Genetic recombination is particularly significant for highly diverse viruses because
it can rescue functional sequences from mutated parental molecules (Mikkelsena 2000).
Theoretically, just as for sexual reproduction, there are two advantages to explain the
evolution of recombination: (1) recombination can create and spread advantageous traits,
and (2) recombination can remove the deleterious genes (Hurst 1996). A great deal of
evidence indicates that viruses can be benefit from recombination. For example, some
plant viruses can repair their genomes by recombining with host transgene transcripts
(Greene 1994, Rubio 1999). There is evidence to show that weak or non-replicative virus
strains can form viable, highly fit viruses through recombination (White 1994, Raju 1995,
Rao 1993). Recombination also has the potential to produce ”escape mutants” or new
pathogenic hybrid strains in nature (Holmes 1999, Suzuki 1998, Worobey 1999b). It has
also been shown that some RNA viruses can achieve new variation by borrowing genetic
material from their host (Meyers 1989, Khatchikian 1989).
7The molecular mechanism of virus recombination is not clear. Two basic theories have
been proposed to account for recombination. One involves the breakage and joining of
DNA/RNA strands. The Holliday model is based on such a process. The other involves
errors of the replication machinery. The most accepted model for the second process is
the copy choice model. The copy choice model is currently considered the most popular
model to explain virus recombination (Nagy 1997). More details about the Holliday
model and the copy choice model are introduced.
2.2.2 Holliday model
The Holliday model is a widely accepted model for genetic recombination. It was
first proposed by Robin Holliday in 1964 (Holliday 1964). The Holliday model explains
the recombination of double-stranded DNA. The steps involved in the Holliday model
are shown in Figure 2.1. The Holliday model proposes that recombination starts by
introducing nicks on the same position of the two parental molecules. Then the nicked
strands pair with the other molecule by invading each other and generate the new unbro-
ken strands which are complementary to the parents. These process requires a special
recombination proteins to catalyze. A cross-strand intermediate which is known as a Hol-
liday junction is produced by ligating the broken strands. The Holliday junction is the
central intermediate in recombination. The direct electron microscopy demonstration of
Holliday junctions has provided clear support for this model. The validity of the Holliday
model has also been proved by a series of experimental result and the crystal structures
(Hays 2003, Rafferty, 1996). Although the Holliday model has been well established, it
has flaws. For example, the Holliday model can not well explain the mechanism by which
two homologous regions of DNA are paired and then nicked.
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Figure 2.1 Holliday model(a) Two viruses from different genotypes simultaneous infect
the same cell. Two homologous molecules line up. (b) Cuts in one strand of
both DNAs. (c) The cut strands cross and join homologous strands, forming
the Holliday structure (or Holliday junction). (d) Heteroduplex region is
formed by branch migration. (e) If the same strands are cleaved a second
time two of the newly synthesized recombinants accompanied with two non-
recombinant DNA molecules will have a region of heteroduplex DNA. (f) If
the other strands are cleaved, then recombinant molecules are generated and
the newly synthesized recombinants will all have a region with heteroduplex
DNA.
9Figure 2.2 Copy choice model (a) Start synthesizing new DNA. (2) Switch to copy other
parental template. (3) Finished new recombinant sequences
2.2.3 The copy choice model
The recombinant molecule is generated by the polymerase as a result of first copying
one parental DNA and then switching to copy a different template (Figure 2.2). Specifi-
cally, the copy choice model postulates that a tip of the growing DNA chain disassociates
from the complementary strand . It anneals to another molecule and serves as a primer
for further DNA synthesis.
The copy choice model is thought to be the primary mechanism involved in recombi-
nation of RNA viruses (Copper 1974). The recombination study on many high diverse
viruses indicates that it is very common to observe multiple recombinant viruses sharing
some crossover points on the same location on the genome with the same parental geno-
types on both side. One of the questions raised by copy choice for this phenomena is
how viruses switch on the same site of two parental genomes when recombination occurs.
The hypothesis is that recombination might be related to some specific DNA sequences
or RNA secondary structures, which indicates the existence of recombination hotspots.
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2.2.4 Other models
Apart from the Holliday and the copy choice models other models are also proposed,
such as the Meselson-Radding model and the double-strand break-repair model. The
difference between these two model is that Meselson-Radding model assumes a single
DNA strand is nicked, and the double-strand break repair model assumes a double-strand
break. Both models are related to the Holliday model by assuming strand invasion and
subsequent DNA synthesis to generate Holliday junction.
2.3 Molecular phylogeny
Molecular phylogeny is the reconstruction of the evolutionary history of taxa based
on molecular data. A phylogenetic tree is the most common depiction of molecular
phylogeny.
2.3.1 Phylogenetic tree
The genetic evolutionary relationship between ancestors and descendants can be col-
lectively describe by a phylogenetic tree (Figure 2.3). A phylogenetic tree is a graph
composed of nodes and branches. The nodes (A,B,C,D, S0, and S1 in Figure 2.3) rep-
resent the taxonomic units, and the branching pattern defines the relationships among
the units. There are two kinds of phylogenetic tree: unrooted (Figure 2.3a) and rooted
(Figure 2.3b). There are three types of nodes in a phylogenetic tree. Nodes connecting
two children and one parents are internal nodes or ancestor nodes (such as S0, S1 in Figure
2.3). Nodes without children are external nodes or leaf nodes (such as A,B,C, and D
in Figure 2.3). For the rooted tree there is a special node without parents that is called
the root (Figure 2.3 b). The branch length represents the amount of evolution that has
occurred along that branch.
Molecular phylogeny has broad application in biology. For example, it has been used
to retrace the evolutionary history of species (Lemey et al. 2003), and to study the
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Figure 2.3 Phylogenetic trees for a data with four taxa
origin of life (Galtier et al. 1999) and viruses (Zhu et al. 1998). It has also been used by
biogeographers to investigate whether biological diversification is correlated with major
geological activity (Buckley 2001). Medical research has benefitted from phylogenetic
analysis by identifying the original virus infection or start of epidemics (Goujon 2000).
Studying the molecular evolution of viruses can also provide scientists a chance to develop
more efficient drugs and vaccines.
2.3.2 Data for phylogenetic reconstruction
We can use sequence information to reconstruct phylogenetic relationship of species.
Phylogenetic reconstruction is based on incomplete information since the internal nodes
a phylogenetic tree represent unobserved historical taxa. In general only the sequence
information of the leaf nodes is available.
To perform phylogenetic reconstruction the similarity of DNA/RNA sequences is
evaluated by assuming all taxa in the analysis are homologous descendents of a common
ancestor. The sequences have to be alignable. Sequences from closely related genes or
species usually differ by only a few point mutations, and the distantly related sequences
may differ by a great number of changes. Large number of mutations can sometimes
lead to no remaining, discernible similarity and unalignable sequences. Given the aligned
data one can determine the positions where nucleotide substitution, insertion and deletion
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Figure 2.4 Intuitive phylogenetic reconstruction from aligned DNA sequences data
have occurred over time.
We use an example to demonstrate phylogenetic reconstruction intuitively. In Figure
2.4a, the aligned data include five species: Human, Monkey, Rat, Frog, and Fish. Each
column, which is one site of the alignment, is represented by a nucleotide pattern. There
are two different types of nucleotide patterns: topologically informative (sites 1, 2, 5, 6)
and noninformative (sites 3, 4). Informative sites must have at least two different kinds
of nucleotides, and each has to be represented by at least two taxa. The informative sites
favor one tree over another. Noninformative sites provide no topological information. An
intuitive way to reconstruct phylogenetic relationship is to collect the nucleotide patterns
of all informative sites of the data and count the number of different sites for any two
pairs of aligned sequences. Based on the sequence alignment the human and the monkey
differ at only one noninformative site for the whole alignment, hence human and monkey
are the closest species on the phylogenetic tree. Rat shares one informative site with both
human and monkey, and shares four sites with frog and 2 sites with Fish. Therefore, we
observe closer relationship between rat and frog than with human and monkey. The fish
shares the fewest sites with all species except frog, so it is only close to frog and is the
most divergent species. In the phylogenetic tree we observe the longest branch length
between fish and all other species, and relatively shorter branch length between human
and monkey.
Most phylogenetic reconstruction methods assume a single phylogeny for the whole
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alignment. However, this assumption is not true for the data with recombinant sequences.
Recombination can produce different evolutionary histories for regions of the data as in
Figure 2.5. Identification of inconsistent phylogenetic relationships along the genome can
be used to detect recombination a fact used by many recombination detection methods.
2.3.3 Model for molecular evolution
As described in the previous section, the simplest measure of distance between two
aligned sequences is to count the number of nucleotide sites at which the two sequences
differ. However, this can be a poor measure of the actual among of evolutionary changes.
If the sequences diverged from the common ancestor a long time ago it is very likely
that the same site has undergone repeated substitutions. As time increases, using the
number of differences between two sequences will underestimate the actual number of
substitutions that occurred. Therefore, a mathematical model describing the evolution
of sequences in time is required to reconstruct phylogenetic relationships. The model can
be built either empirically or parametrically. The model used in my thesis is a parametric
model which follows the common assumptions for modeling evolution of molecular data.
Given a topology, mutations are assumed to follow a continuous time Markov process
(CTMC). The CTMC is parameterized in terms of an infinitesimal rate matrix. This
Markov process is assumed to be homogeneous, stationary, and reversible. Homogeneity
means that the rate matrix is independent of time, which indicates the patterns of nu-
cleotide substitution remains the same in different parts of the tree. Stationarity means
that the nucleotide frequencies have remained the same during the course of evolution.
Reversibility with stationarity means that an evolutionary outcome if suddenly viewed
reverse would have the same probability of occurring as it did in the forward direction.
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Figure 2.5 How does recombination affect molecular phylogeny: Phylogenetic relation-
ships of recombination data (a) A recombination event leads to a non bi-
furcating tree. (b) A single phylogenetic tree is not able to explain the
evolutionary history of the recombinant data. On the left hand side of the
genome the recombinant sequence (query) is grouped with D sequence, and
on the right hand side with A.
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The most general form of the rate matrix is
Q = (qij) =


A C G T
A · piCa piGb piT c
C piAd · piGe piT n
G piAg piCh · piT i
T piAj piCk piGl ·


, f = [piA piC piG piT ],
where f represents the equilibrium bases frequencies of the four nucleotides. The diago-
nals of the Q matrix are chosen qii = −
∑
i6=j qij so the rows sum to zero. Each entry of
the matrix qij represents the substitution rate of changing from nucleotide i to j, where
i, j ∈ (A,C,G, T/U). The transition probability can be calculated by qij = pijpij, where
pij is the relative substitution rate, and pii is the base frequency. The most general model
has different pij and pij, which involves too many parameters and can cause computa-
tional difficulty. Assumptions are usually made to simplify the model. The reversibility
assumptions implies pij = pji for all i 6= j. Based on this assumption the parameters in
the transition matrix will be decreased from 12 to 6. Mutations between the same type
of nucleotide (purine to purine or pyrimidine to pyrimidine) are called transitions, muta-
tions between different nucleotide types are transversions. Previous studies of DNA data
have shown that transition occurs in consistently higher frequencies than transversion
(Brown 1982, Gojobori 1982, Curtis 1984, Wakeley 1994, 1996). To accommodate this
observation, models such as HKY85 (Hasegawa 1985) and Kimura 2 parameters (Kimura
1980) make further simplification by allowing two nucleotide substitution rates (transi-
tion or transversion). The difference between the HKY85 and the Kimura 2 parameter
models are that the latter model assumes uniform equilibrium base frequencies. The
simplest model is the Jukes Canter model (JC) which assumes all mutations have the
same infinitesimal rate (qij = q) for all i 6= j.
The HKY85 matrix is so far the most popular model and is also the model used in
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my study. The transition matrix of the HKY85 model is
Qt =


A C G T
A · αpiC βpiG βpiT
C αpiA · βpiG βpiT
G βpiA βpiC · αpiT
T βpiA βpiC αpiG ·


, f = [piA piC piG piT ]
The equilibrium frequencies f can be fixed to the observed nucleotide frequencies in the
data for computational ease.
To compute likelihoods on a tree, one needs transition probabilities, for example
the probability that nucleotide A mutates to G in t units of time. Let X(t) be the
nucleotide state of a position at time t. Then we need the transition probability function
Pij(t) = P [X(t) = j|X(0) = i]. The rates are related to transition probabilities by
qij = lim
t→0
P [X(t) = j|X(0) = i]/t
The transition probability functions satisfy the forward Kolmogorov equations,
dPij(t)
dt
=
∑
k
qkjPik(t), for t ≥ 0.
In general, let P (t) = Pij(t), then the forward equations can be written in matrix form
P ′(t) = dP (t)/dt = P (t)Q,
where Q is a particular rate matrix. The solution is
P (t) = etQ.
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2.3.4 Likelihood methods assuming a model of evolution
The maximum likelihood method introduced in this section assumes a tree relation-
ship between the observed taxa. The model usually includes parameters such as topology
τ , branch lengths T of the tree, and additional evolutionary parameters θ, such as the
nucleotide substitution rate.
Consider a sequence alignment with N taxa and length L. The data can be summa-
rized as D = (S1, S2, · · · , SL), where Si is a vector of nucleotides with Sik ∈ A, C, T, or G
for k = 1, 2, · · · , N . By assuming a strictly bifurcating topology, there are N − 2 inter-
nal nodes, and 2N − 3 branches where N − 3 are internal branches and N are external
branches. The total number of possible topologies of the given data is (2N − 5)!! =
(2N − 5)× (2N − 3)× · · · × 3. The likelihood of observing data D given the parameters
is
L(D|τ, T, θ) =
L∏
i=1
L(Si|τ, T, θ),
where θ represents the evolutionary parameters, and T = (t1, · · · , tN , tN+1, · · · , t2N−3) is
the vector of branch lengths. The likelihood of observing the nucleotide pattern Si at
any site i is
L(Si|τ, T ) =
∑
yi,N+1
· · ·
∑
yi,2N−2
piyi,2N−2 ×
[
N∏
k=1
P (Sik|yiσ(k), τ, tk)
]
×
[
2N−3∏
k=N+1
P (yik|yiσ(k), τ, tk)
]
,
where σ(k) is the node immediately ancestral to node k, and piyi,2N−2 represents the
equilibrium base frequencies , P (yik|yiσ(k), τ, tk) is a transition probability between two
internal nodes, and P (Sik|yiσ(k), τ, tk) is the transition prbability along an external branch
given the state of the internal node, the topology τ , and the branch length t.
We assume the branch lengths tk are independent identically distributed exponen-
tial random variables with mean µ, to reduce the number of parameters in the model
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(Suchard, 2001). Integrating out the branch lengths leads to the likelihood of observing
the whole data
L(D|τ, µ, θ) =
L∏
i=1
L(Si|τ, µ, θ),
where θ = (κ, µ).
2.3.5 Methods for phylogenetic reconstruction
DNA/RNA nucleotide sequences provide a rich data source for phylogenetic recon-
struction. Converting information in sequences into an evolutionary tree, including topol-
ogy, or node relationships and branch length, is the process of phylogenetic reconstruc-
tion. Many methods have been developed for this purpose. Most methods belong to
one or more of the following categories: (1) distance methods (Farris 1972) summarize
aligned data as evolutionary distances, (2) maximum parsimony (Lake 1987, Fitch, 1971,
Felsenstein, 1988) assumes the tree with fewest mutation is the best, and (3) maximum
likelihood (Felsenstein 1981) infers the tree with the highest likelihood. In the past few
years, likelihood-based methods have expanded to include Bayesian approaches. These
Bayesian methods use Markov chain Monte Carlo (MCMC) simulation (Metropolis et
al. 1953) to produce a posterior distribution of topology. Specifically various methods
have been developed for identifying recombination from molecular data. For example,
one method finds recombination crossover points by maximizing Chi− square statistics
of sites before and after support different relationships among the sequences (Smith et
al. 1992), another method uses the distribution of polymorphic sites along a sequence to
detect recombination (Stephens et al. 1985, Sawyer et al. 1989). More than one methods
use bootstrapping (Salminen et al. 1995, Lawrance et al. 1992), and graphical methods
(McGuire et al. 1997). Likelihood based methods (Grassly et al. 1997), and homoplasy
test (Smith et al. 1998) are also introduced in the literature.
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2.4 Bayesian inference
Bayesian probability theory describes a problem by combining common-sense knowl-
edge and observational evidence into a single model of uncertainty. It starts by formu-
lating a prior distribution over the unknown parameters of the model that captures our
beliefs about the problem prior to seeing the data, then obtains a posterior distribu-
tion. Compared to the maximum likelihood method, that estimates unknown parame-
ters by finding the parameter values that maximize the likelihood, estimating parameters
by Bayesian inference usually requires integration instead of maximization. Numerical
method developed in 1950s combined with new technology make Bayesian i calculations
tractable for complicated models.
Let D be the data and let θ represent the unknown parameters. By Bayes rule
P (θ|D) = L(D|θ)× q(θ)
g(D)
. (2.1)
The conditional distribution of the parameters given the data P (θ|D) is the posterior
distribution, the target in Bayesian inference. L(D|θ) is the likelihood function, which
can be interpreted as a conditional distribution that specifies the probability of the data
given some value of the parameters. The prior q(θ) is the probability distribution of the
parameters before observing the data. The denominator g(D) =
∫
L(D|θ)×q(θ)dθ is the
marginal likelihood of the data. Since g(D) is a normalizing constant that can usually
be ignored, equation (2.1) can be written as a proportion
P (θ|D) ∝ L(D|θ)× q(θ).
2.4.1 The Markov chain Monte Carlo (MCMC)
As the dimension of θ increases, analytic evaluation of the posterior distribution
quickly becomes impossible. The posterior distribution may be approximated using the
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MCMC method. The method relies on simulating a stochastic process, a Markov chain,
to estimate the property of some probability distribution by the Monte Carlo method.
Simple Monte Carlo sampling evaluates the expectation E[g(θ)] against a target dis-
tribution by drawing samples (θt, where t = 1, · · · , n) from the target distribution. If
g(θ) is an indicator function
g(θ) =


1, if A is true
0, o.w.
then E[g(θ)] = P [A]. Thus, the samples themselves estimate P (θ). When the sample size
n is large and samples θt are independent, Monte Carlo approximates the expectation
with a finite sum
E[g(θ)] ≈ 1
n
n∑
t=1
g(θt).
In a realistic situation drawing independent samples is not feasible. However, it
is relatively easy to draw a dependent sample from a discrete time Markov chain. A
discrete time Markov chain is a series of random variables for which the distribution
of each element depends only on the previous value. Let θt be the state (value of the
parameter) at the tth iteration. The Markov condition is
P (θt = j|θ0 = i0, θ1 = i1, · · · , θt−1 = it−1) = P (θt = j|θt−1 = it−1).
MCMC performs Monte Carlo estimation of quantities of interest by sampling dependent
values θt, t = 1, 2, · · · , n from a Markov chain, which is designed to have the equilibrium
distribution of interest. If the Markov chain runs long enough, the starting state θ0
will be forgotten and the chain will achieve the equilibrium distribution, in this case the
desired posterior distribution. The Markov chain is said to converge to the stationary
21
distribution. As before posterior means are estimated as
E[g(θ)|D] ≈ 1
n
n∑
t=1
g(θt).
Bayesian inference requires special algorithms to construct a Markov chain whose the
stationary distribution is the desired posterior distribution.
2.4.2 Metropolis-Hastings (MH) and Gibbs sampling algorithms
One of the most famous algorithms for constructing a Markov chain with the desired
stationary distribution is the Metropolis-Hastings algorithm (Hastings 1970, Metropolis
et al. 1953). The MH algorithm uses an acceptance/rejection rule to move between
states. Applying the MH algorithm, the Markov chain begins at a starting point θ0
drawn from a starting distribution. A proposal distribution is then required to propose a
new value for the parameter. Theoretically the proposal distribution can be arbitrary; for
any nth iteration, the new θn+1 can, but need not depend on the current value θn = θi.
However, choosing a proposal distribution close to the target distribution will help the
Markov chain mix well and converge more rapidly. The move from θi to θj is proposed
with some transition probability qij = q(θj|θi), and will be accepted with probability αij.
αij = min
(
1,
pi(θj)× q(i|j)
pi(θi)× q(j|i)
)
,
where q(i|j)
q(j|i)
is the proposal ratio, and
pi(θj)
pi(θi)
is the posterior ratio,
pi(θj)
pi(θi)
=
P (θj|D)
P (θi|D) =
L(D|θj)q(θj)
L(D|θi)q(θi) .
The acceptance probability αij is important since it determines how efficiently the chain
moves around the sample space. A sign of inefficiency is an unacceptably high rejection
rate, ie. low αij. If the candidate θj is accepted, then θn+1 = θj. Otherwise θn+1 = θi.
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A large parameter space θ might cause low acceptance probabilities αij using the
MH algorithm, especially when attempting to update all parameters at once. Another
algorithm, Gibbs sampling (Lawrence 1993), can be useful. Gibbs sampling divides the
parameter θ into d subvectors, and updates one subvector at a time conditional on the
current values over all others. A simple example is used to describe this process. Assume
the parameters are divided into three subvectors θ = (κ, µ, ρ). In the current state the
parameters have value θn = (κn, µn, ρn). It takes three steps to update all parameters
using the Gibbs sampling algorithm by cycling through one subvector at a time.
κn+1 ∼ q1(κn+1|µn, ρn)
µn+1 ∼ q2(µn+1|κn+1, ρn)
ρn+1 ∼ q3(ρn+1|µn, κn+1)
The proposal distributions q1, q2, q3 can be built from MH steps. Indeed, Gibbs sampling
can be considered a special case of the MH algorithm.
In this thesis a Metropolis-Hastings within Gibbs sampling algorithm is used. For
each step a subvector of parameters is updated and accepted/rejected based on the MH
algorithm. If there are d variable subvectors, d steps are needed to update all of θ.
More details about applying this algorithm to phylogenetic inference will be given in the
following chapters.
2.4.3 Reversible jump MCMC
In some circumstance it is desirable to estimate a parameter θ whose dimension is not
fixed. Constructing a Markov chain for MCMC samplers that jump between parameter
spaces of varying dimension is a much more complicated issue. Reversible jump MCMC
(rjMCMC) (Green 1995) was introduced to allow MH in multiple dimensions, and has
been widely applied to Bayesian model determination problems (Dellaportasand 1999,
Richardson 1997, Fan 2000, Moller 1999). The critical issue to construct a Markov chain
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that jumps between subspaces of varying dimensions is the maintenance of detail balance
with respect to the posterior distribution. Detail balance requires
pi(θi)P (θj|θi) = pi(θj)P (θi|θj)
for all parameter states θi 6= θj, where αijq(θj|θi) is the transition probability, and θi and
θj may have different number of parameters. Detail balance is a sufficient condition to
guarantee that the chain converges to a stationary distribution.
A key feature of rjMCMC is to introduce additional random variables to match the
parameter space dimensions across trans-dimensional proposals. For example, assume
the parameter dimension for θk is Dk, and for θk∗ is Dk∗ , where Dk∗ 6= Dk. To perform
rjMCMC one must introduce two random vectors u and u∗, which satisfy Dk +dim(u) =
Dk∗ +dim(u
∗) and for which there exists a one-to-one deterministic function f such that
(θ∗, u∗) = f(θ, u). If Dk∗ > Dk one can use a null vector u
∗ so Dk + dim(u) = Dk∗ . Let
bk∗ be the probability of jumping from lower dimension Dk to higher dimension Dk∗ , and
dk be the reverse probability from higher to lower dimensional space. Then the proposal
distribution for increasing dimension from Dk to Dk∗ is
q(θ∗|θ) = q(u|θk)× bk∗ .
The reverse proposal distribution q(θ|θ∗) can be calculated from q(θ∗|θ) using the Jaco-
bian of transformation function g. The Metropolis-Hastings ratio for the proposal θ → θ∗
is:
αk,k∗ =
{
1,
L(D|θk∗)× q(θk∗)
L(D|θk)× q(θk) ×
dk
bk∗ × P (θk|θk∗) ×
∣∣∣∣∂g(θ, u)∂(θ)
∣∣∣∣
}
.
More details of the rjMCMC moves used in the DMCP and other models of my thesis
are included in the appendix.
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2.4.4 Practical issues and convergence diagnosis in MCMC
There are practical issues for applying MCMC to solve real problems A Markov chain
that can mix well for a complex model is tricky to achieve. A well mixing Markov
chain reaches its stationary distribution quickly. The first several iterations before the
stationary distribution is recorded, , the burn-in samples, are usually discarded. Once
equilibrium is achieved approximately independent draws for Monte Carlo approximation
can be obtained by subsampling a MCMC simulation every m observations, where m is
a thinning parameter to be tuned. Another advantage of subsampling is to save storage
space. However, it is not always good to increase the thinning parameter. As the thinning
parameter increases, the output is less dependent, but the accuracy of the asymptotic
approximations decreases. Convergence diagnostics are used to choose the best burnin
and subsampling rates.
There have been many ways to test MCMC convergence. Mykland et. al(1995) and
Johnson (1998) designed algorithms to produce independent draws from the target distri-
bution. Rosenthal and Cowles uses theoretical (analytic) results to bound the difference
between the simulation and the target distribution after some specific number of iter-
ation(Rosenthal 1995, Cowles 1998). There are also methods to detect the mixing of
Markov chain samplers. For example, Yu (1995, 1998) monitors trends in the simula-
tion; Raftery suggests checking the autocorrelation (Raftery 1992), and Gelman (1992)
monitors mixing of sequences Monitoring the convergence can be based on running many
short Markov chains (Gelfand 1992), running a few long chains (Gelman 1992a,b), or
running one very long chain (Geyer 1992). It is now agreed that running many small
chains can misguide the result (Geyer 1992). Whether a few long runs or a single ex-
treme long run should be preferred is not clear. However, Geyer declared that a single
long run has the best chance to traverse the whole parameter space (Geyer 1992), and
comparison between chains can never prove convergence. When multiple runs are used,
it is known that starting values may affect convergence diagnostics for MCMC because
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of slow-mixing chains. Therefore, the starting distribution must be chosen carefully. It
is suggested to use ’over-dispersed’ starting values by Gelman and Rubin when several
long chains are run.
Details of the Gelman and Rubin method (1992b) are given here since it is the method
used in the thesis. The method involves two steps for testing convergence based on
two or more chains. The first step is to obtain an overdispersed estimate of the target
distribution and to generate start value for each chain from this distribution. Then using
the formula √
Rˆ =
√(
n− 1
n
+
m + 1
mn
B
W
)
df + 3
df + 1
to estimate the target distribution of the scalar quantity as a conservative Student t
distribution. In the formula, n is the length of the chain, m is the number of the chains,
B is the variance between the means of all chains, W is the variance within each chain,
and df is the degrees of freedom. If the chain converged, the shrink factor
√
Rˆ is suppose
to be close to 1.
2.4.5 Inference using posterior samples
Point estimates of the unknown parameters can be produced from the posterior distri-
bution. The most often used posterior point estimates in Bayesian inference are moments,
quantiles, medians, or modes.
One way to compare hypotheses in Bayesian analysis is to calculate the Bayes factor
for the null hypothesis (H0) against the alternative (Ha). The Bayes factor requires that
the prior of the two hypotheses are known. The Bayes factor is defined to be the posterior
odds over the prior odds
BF01 =
P (H0|D)q(H1)
P (H1|D)q(H0)
To interpret the Bayes factor, Jeffreys (1961) suggested to use half-units on the log10
scale. Table 2.4.5 shows the interpretation we apply in this thesis.
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log 10(BF01) BF01 Evidence support H0
0 to 0.5 1 to 3.2 Not worth mention
0.5 to 1 3.2 to 10 Substantial support
1 to 2 10 to 10 Strong support
> 2 > 100 Decisive support
Table 2.1 Bayes factors in favor of H0
2.4.6 Prior
An important issue in hypothesis testing for Bayesian inference is the sensitivity of
the Bayes factor to the priors. In the Bayesian approach it is very likely that the Bayes
factor is more sensitive to the choices of prior than the estimation. It is possible to
observe contradictory conclusion based on Bayes factor computed with different priors
(Kass 1989). It is important to evaluate the Bayes factor over a range of possible prior
probabilities q(H0), but may be computationally intensive (Kass 1994). If the estimation
is obtained under the prior in favor of H0 P (θ|H0) À P (θ|Ha), the Bayes factor might
show the data are more unlikely under Ha than under prior not in favor either hypotheses.
To solve this conflict we can choose a noninformative proper prior. Bartlett (1957) noted
that there is a consequence to use a noninformative prior widely spread on θ under Ha
in this situation. It will cause the Bayes factor to favor H0. To overcome this difficulty
a proper priors is suggested. Therefore, to define a reasonable prior such that the Bayes
factor can be used to test hypothesis requires the prior ratio is not to be too far from 1
(Kass 1994).
2.5 Two important human pathogenic viruses
In this section I will introduce two of the most important human pathogenic viruses:
human immunodeficiency virus 1 (HIV-1) and hepatitis B virus (HBV), which are the
two viruses studied in my thesis.
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2.5.1 HIV-1
HIV-1 is the major cause of the most dangerous human disease, AIDS. It has killed
more than 25 million people since it was first recognized in 1981. Currently over 40
million people globally were estimated to be living with HIV. In the year 2005 alone
more than 3 million and close to 5 million people acquired HIV (UNAIDS/WHO).
HIV-1, a retrovirus, has a genome made of two identical RNA strands. The HIV
genome is about 9800 nucleotides, which has nine open reading frames and encodes
15 proteins. One of the major characteristics of HIV is its high genetic variability.
The high diversity of HIV is the result of the high error rate of reverse transcriptase
(RT)(Preston 1988), the high recombinogenic rate of RT (Hu 1990), and the fast turnover
of virions in HIV-infected individuals (Ho 1995, Wei, 1995). Phylogenetic analysis of
HIV-1 strains reveals very distinctive HIV-1 lineages M, N, and O. M is found to be
the major lineage responsible for the virus worldwide pandemic. Within M there is
further phylogenetic structure. So far nine genotypes (A-D, F-H, J and K) have been
defined in group M. Within genotypes A and F sub-genotypes A1, A2 and F1 and F2 have
been described. Some recombinant genomes have been identified in several, apparently
unlinked, individuals and are designated as ”Circulating Recombinant Forms” (CRF).
HIV CRFs play a major role in the global AIDS epidemic.
2.5.2 HBV
Compared to AIDS, hepatitis B is a less lethal disease caused by HBV which attacks
the liver. HBV has been found in humans much longer than HIV. HBV can cause lifelong
infection, cirrhosis of the liver, liver cancer, and liver failure. Based on conservative
estimates there are 350 million carriers of HBV world-wide, and 5% to 10% develop
chronic hepatitis B. Despite a much lower rate lethality (about 1% ), almost 1.2 million
people worldwide still die each year from HBV related diseases due to larger infected
population. Although the genomes of HIV and HBV are very different, both viruses have
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very high genomic diversity. HIV and HBV have been classified into various genotypes,
and the genotypes for both viruses have distinct geographical distributions.
HBV is an incomplete circular double-stranded DNA virus. HBV is known as the
virus with the smallest genome, approximately 3200 base pairs. It has compact organiza-
tion with four overlapping reading frames running in one direction, and encoding seven
different proteins. There are no noncoding regions in the HBV genome. As a DNA virus
the unique characteristic of HBV is that during its replication the virus goes through
reverse transcription . This step in replication is likely to be the reason that HBV is
the only DNA virus known to recombine. Eight genotypes (A-G) have been defined for
HBV (Bartholomeusz 2004). However, genotype E is found to be a recombinant strain
by itself (Bartholomeusz 2004). There is limited previous study for HBV genotyping and
recombination. Therefore, many HBV published full-length sequences are not assigned a
genotype, and many might be recombinants.
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CHAPTER 3 INVESTIGATING THE ROLE OF
REPRESENTATIVE DATA TYPES FOR RECOMBINATION
STUDY
Table 3.2 in this chapter is published in: Are you my mother? Bayesian phyloge-
netic inference of recombination among putative parental strains. Appl Bioinformatics.
2003;2(3):131-44.
3.1 Introduction
It is important to study virus genetic evolutionary history. Many pathogenic viruses
have high variation and recombination rate. Recombination has been found to be one of
the major forces for viruses evolution. By recombining two parental genomes into one
offspring recombination causes tremendous genetic changes, which can provide viruses a
chance to evade attack from the immune system and drug treatment. It has been hypoth-
esized that recombination might play an important role for virus co-species transmission
(Goebel 2004, Rest 2002). Previous study has shown that for some viruses the infecting
genotypes are related to the prognosis of the disease (Sugauchi 2003, Nakayoshi 2003,
Chan 2003, Sumi 2003). Therefore, determining the virus genotype and understanding
the mechanism of virus recombination are important, not only for epidemiological studies
to predict sequences of the emerging viruses, but also for efficient vaccine development
and drug treatment of major viral diseases (Hahn 1994, Bartholomeusz 2004).
Recombination study involves identifying the occurrence of recombination, estimating
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parental genotypes, and evaluating locations of cross over points (COPs). With new tech-
nology, the rapid determination of nucleotide sequences allows us to study virus evolution
based on analyzing molecular sequence data. Many statistical models have been devel-
oped for virus genotyping and recombination identification (Posada 2001, Posada 2002).
One of the most popular methods for recombination identification is phylogenetic-based
method. Phylogenetic methods infer recombination according to the identification of in-
consistent topologies along the aligned sequences. The disadvantage of the phylogenetic-
based method is that it suffers from low power as the sequence diversity decreases. Also
large data sets leading to a huge number of possible topologies can cause computational
difficulties. So there is a limit to the number of sequences that can be included in the
data.
One way to decrease the data size is to choose representative sequences by taxon-
sampling methods. Taxon-sampling methods use a single or a few sequences to represent
each clade/genotype. In general the more taxa sampled in the data, the more accurate
the inferred phylogeny will be. Many studies focus on revealing how many sequences and
how long the sequence alignments should be to obtain an accurate phylogenetic inference
(Hillis et al. 2003, Rosenberg et al. 1998, Bruce et al. 1998, Poe, 1998a, Graybeal, 1998,
Poe, 1998b). Although most of studies do not have a final conclusion on this issue, it
is reported that incomplete sampling should not cause trouble to infer the phylogenetic
relationship of the clade (Rosenberg et al. 1998). Another way to improve the accuracy
of phylogenetic inference is to find the best sequence representatives for each genotype.
Three representative data types, the ancestral, consensus, and exemplar data were pro-
posed by Bininda-Emonds (1998). However, taxon-sampling has not been studied in the
context of recombination study. Many of the same principles in previous taxon sampling
study should apply in recombination study. The recombination application can be a very
sensitive test for comparing taxon sampling methods.
Comparing taxon sampling methods in the context of recombination requires a good
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recombination detection method. The method used in the current study is a Bayesian
phylogenetic-based multiple change points model (BMCP) (Suchard et al. 2002). One
of the advantages of the BMCP method is that it provides a framework to avoid the
sequential trap encountered by most recombination detection methods, which is using
the same data to estimate recombination and to test the hypothesis. The BMCP can
simultaneously estimate and tests recombination from a posterior distribution. Similar as
other phylogenetic-based methods (Grassly et al. 1997, Holmes 1999, Martin 2000) the
BMCP method infers recombination by identifying inconsistent topologies on different
regions of the aligned sequence data . In this chapter we first introduce three new taxon-
sampling methods, then use the BMCP method we report the different performance of
various representative data types on simulated recombination data.
3.2 The BMCP recombination detection model
The data for the BMCP method are N + 1 aligned DNA sequences with length S.
The first N sequences are representatives for P possible parental genotypes, and the
last sequence is a putative recombinant sequence. A continuous time Markov chain
(CTMC), specifically HKY85, is used for nucleotide substitutions. The model assumes
the alignment can be divided into independent, non-overlapping segments by M + 2
change points ξ = (ξ0, ξ1, ξ2, · · · , ξM+1) Two special topology change points ξ0 and ξM+1
are set as the start and the end of the alignment. The model assumes that within each
segment all sites have independent and identical distribution (iid). Other parameters
in the model are κ = (κ0, κ1, · · · , κM) related to the transition : transversion ratio,
µ = (µ0, µ1, · · · , µM) representing the average branch length, and τ = (τ0, τ1, · · · , τM)
topologies. For any segment k there is a single κk, a single µk, and a single τk. For
computational ease the model assumes a fixed parental tree. Allowing the putative
recombinant sequence to branch out from the fixed parental tree leads to 2N − 3 total
possible topologies.
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The BMCP model does not distinguish the topology change points and the evolu-
tionary parameter change points. Therefore, any two adjacent segments can have either
identical topology or evolutionary parameters, or both are different. Let k be the index
of a segment, and sk be the start site of the segment k. The likelihood of observing data
D given the parameters of the model is
P (D|θ) = P (D|M, ξ, κ, µ, τ)
=
M+1∏
k=1
sk+1−1∏
i=sk
P (di|κk, µk, τk)
where dii is the nucleotide data at site i. The detail of the parameter priors in the BMCP
model have been given in the previous paper (Suchard 2002).
3.3 Strategies of taxon-sampling
Taxon-sampling uses the consensus, exemplar, or ancestral sequences to represent a
genotype. Generating the representative sequence(s) requires the collection of unrelated
nonrecombinant sequences for each genotype. However, not all of the nonrecombinant
sequences are appropriate for generating representative sequences. The nonrecombinants
which are isolated from the same person or proved to be closely related have to be
removed. In our study all sequences reported to be isolated from the same patient are first
excluded from our study. Then for the rest of nonrecombinant sequences we calculated
pairwise distance. The sequences with pairwise distance less than 0.01 were considered as
closely related sequences and were also eliminated. The remaining sequences were used
as the data to generate different representative sequences.
Both consensus sequence and exemplar sequence can be easily generated as described
in the following sections. Consensus and exemplar method are both commonly used
taxon-sampling methods. However, both two methods are not perfect. To overcome the
limitation of consensus and exemplar methods we introduce three new methods: fre-
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Figure 3.1 Topology of representative data with four genotypes. The leaf nodes
(S1, S2, S3, and S4) are representative sequences generated by different
method for the corresponding genotypes
quency method, conditional ancestor method, and modal conditional ancestral method.
3.3.1 Consensus methods (CONS)
The consensus method obtains a representative sequence by summarizing each posi-
tion as the nucleotide observed in the majority of sequences from the genotype. Usually a
consensus sequence is considered a good summary of each genotype. The advantage of us-
ing the consensus method is that there is only one sequence to represent each genotype,
and each site of a consensus sequence is a specific nucleotide represented by majority
representative sequences of the genotype. The likelihood calculations of the consensus
method are simple. Figure 3.1 is the topology of a data with four taxa (S1, · · · , S4),
which are the consensus sequences for the corresponding genotypes in current case. The
likelihood of observing the data di at site i given the current topology and evolutionary
parameters is
P (Si|τ, θ) =
∑
S0
piS0
∑
S5
P (S1|S0, τ, θ)×
P (S2|S0, τ, θ)× P (S3|S5, τ, θ)× P (S4|S5, τ, θ)× P (S5|S0, τ, θ),
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where τ the topology, and θ = (κ, µ) are the evolutionary parameters, the ti/tv ratio κ
and average branch length µ. However, the consensus method ignores information from
the majority sequences. The consensus sequence is a man-made sequence and may not
be biologically meaningful. Therefore, we want to introduce other methods and look for
the best representative method.
3.3.2 Exemplar method (EXEM)
The exemplar method randomly chooses one or a few sequences to represent the
corresponding genotype. It is the most commonly used taxon-sampling method for re-
combination studies. Over 90% references for our HBV study chose to use exemplar
representatives. Exemplar method allows to use more than one sequences to represent
each genotype. The exemplar sequences are real sequences with more biological meaning.
The likelihood calculation for the exemplar method is the same as the consensus method.
3.3.3 Frequency method (FREQ)
The frequency method summarizes each site of a genotype as a vector of the observed
nucleotide frequencies in the sampled sequences. The representative data is not a specific
nucleotide as consensus or exemplar data. For each site the data on a leaf node is
represented by a vector of nucleotides′ frequencies. Let S1 · · ·S4 in the same topology of
Figure 3.1 represent vectors of nucleotide frequencies for the corresponding genotypes.
The likelihood is
P (Si|τ, θ) =
∑
S0
piS0
∑
S1
∑
S2
∑
S3
∑
S4
∑
S5
P (S1|S0, τ, θ)
fS1P (S2|S0, τ, θ)fS2P (S5|S0, τ, θ)P (S3|S5, τ, θ)fS3P (S4|S5, τ, θ)fS4 ,
where piS0 is the equilibrium frequency of node S0, and fSi represents the frequency of Si
being a specific nucleotide for genotype i.
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3.3.4 Conditional ancestor method (CA)
The ancestor method infers the ancestral state of the genotype. The ancestral se-
quence is historical information that is almost never available. Therefore, the ancestral
sequence has to be estimated by statistical methods. The CA method calculates the
conditional ancestral probabilities as the normalized conditional likelihoods at the most
recent common ancestral node of a genotype. Figure 3.2 demonstrates the calculation
of the conditional likelihoods used by CA method. The conditional likelihoods for
ancestral node of genotype A (labeled 1 in figure 3.2) is
L{Ai=i} = pii
∑
A5
∑
A6
P (A5|i, t5, θ)P (A6|i, t6, θ)P (A1|A5, t1, θ)
P (A2|A5, t2, θ)P (A3|A6, t3, θ)P (A4|A6, t4, θ)
where pii are the equilibrium frequencies and θ = κ in this case.
The conditional ancestral probabilities are calculated assuming a known tree which
is inferred using the neighbor joining method (Felsenstein 1985) of the Phylip package
(Felsenstein 1993). Once the conditional ancestral probabilities are calculated, the like-
lihood given the genotype tree is the same as the frequency method introduced in the
previous section. Unlike the consensus sequence the ancestral sequence is a real sequence
which existed in the past and has biological meaning. CA methods includes more of
the information, particularly evolutionary information from the original data and has a
potential to lead to a less biased results. Since the CA method uses more comprehensive
representative data it involves lengthier calculations. The computational time is slower
than consensus or equivalent methods.
3.3.5 Modal conditional ancestral method (MCA)
The modal conditional ancestral method is simplified by CA method, where each
position at the parental data is the nucleotide with the maximum conditional likelihood.
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Figure 3.2 Conditional likelihood calculation for CA method
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The MCA method has the same likelihood calculation as the consensus method and is
just as efficient.
3.4 Simulation study on representative data types comparison
The different performance on recombination detection using the consensus, exemplar,
frequency, CA, and MCA methods were compared by three simulation studies. In sim-
ulation study case one We compared the consensus, exemplar, and MCA methods on
simulation data with the same diversity as HIV envelope gene sequences. Due to the low
power of phylogenetic-base methods on testing the data with low diversity in simulation
case study two we examine the recombination identification on consensus method and
the methods with more comprehensive representative data types. Both consensus and
MCA methods were tested as good methods in the first two simulation studies. For the
third simulation study we focus on comparing consensus and MCA methods under some
special scenario.
3.4.1 Case study one: Comparison of consensus, exemplar, and MCA
methods
The first simulation study is based on a phylogeny generated from real HIV envelope
gene sequences (Figure 3.3). Twenty unrelated and nonrecombinant HIV envelope
sequences for each genotype A, B, C, and D were extracted from the HIV database.
The phylogeny is inferred by Phylip’s (Felsenstein 1995) neighbor joining method. One
hundred data sets were simulated by SeqGen, a program that simulates the evolution
of nucleotide sequences along a given phylogeny. The data is simulated assuming the
HKY85 model (Hasegawa et al. 1985). The transition:transversion ratio is set up to 2
and the nucleotide frequencies are piA = 0.26, piG = 0.28, piC = 0.23, piT = 0.23, which
is calculated based on the real data. For each data set a recombinant sequence was
generated by combining the 5′ end of sequence A20 with the 3
′ end of sequence C15. Both
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Figure 3.3 Topology from the original HIV env data. There are total 4 genotypes. The
first letter of each sequence represents its genotype.
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parental sequences are deep rooted sequences which are more likely to cause difficulties for
phylogenetic inference. Due in the realistic situation it almost impossible for us to include
parental sequences in the data we excluded the parental sequences, and one sequence
from genome type B and D for our simulation study. The length of the simulation data
is 1200 base pairs, and the COP location is set up at position 600bp. For each data set,
consensus, exemplar, and MCA representative data were generated and used to test for
recombination by the BMCP model.
3.4.2 Case study two: Comparison of consensus, frequency, and condi-
tional ancestral methods
It is known that phylogenetic-based recombination detection methods suffer from low
power as diversity decreases (Crandall 1999, Posada 2001, Posada 2002). Case study one
shows consensus and the MCA methods are both doing well on high diverse data. Our
hypothesis is that the methods with more comprehensive data types might give better
inference due to including more information in the data. The consensus, frequency,
and CA methods were compared on the simulation data sets with lower diversity. The
diversity was decreased by proportionally shrinking the branch lengths of the topology in
Figure 3.3. One hundred alignments with 98%−99%, 97%−98%, and 95%−96% average
pairwise sequence similarity were generated. The branch lengths of the corresponding
similarities are 10, 8 and 5 times lower than the original HIV envelope tree. The data
sets were prepared and analyzed under the same conditions as in simulation case study
one.
3.4.3 Case study three: The comparison of consensus method and MCA
method
Consensus method is the most commonly used method. A simple simulation is used to
demonstrate that under certain situations the MCA method provides better inference of
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Figure 3.4 Phylogeny of simple simulation for comparing consensus method and MCA
method
recombination than consensus method. The data were generated based on the topology
in Figure 3.4, where there are a total 28 sequences in four genotypes. Genotype A
and C both consist of two distinct subgroups, one majority group and a second deep-
rooted minority group. The branch lengths between and within genotypes is similar to
the real HIV sequences used in the first two simulation studies. We select recombinant
parents from genotypes A and C that are phylogenetically distant from the majority
of genotype sequences. A recombinant query was simulated by combining A1 and C10
at nucleotide 600 in a total alignment of length 1200. One hundred alignments were
generated using Seq-Gen. Consensus and MCA data were generated after excluding the
parental sequences and the resulting alignments were tested with the BMCP model.
3.4.4 Techniques for analyzing result
There are practical issues of analyzing the result from Bayesian model. To obtain
a converged Markov chain we set up the run-length to be 2000000 with 10% burnin.
We chose the 1000 subsample which leads 1800 samples in the posterior file. For each
data set we run two independent chains. The convergence of the MCMC is diagnosed
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by Gelman and Rubin method. We considered the Markov chain is converged with
the shrinking factor smaller than 1.03. We compared the methods on the estimation
of posterior probability of recombination, the median COP locations, and the posterior
probability of true recombinant structure (ppTRS).
3.5 Result
For case study one, all consensus, exemplar, and MCA methods have 100% posterior
probability support of recombination. However, the methods perform differently for
estimating the COP locations and identifying parental genotypes. The Wilcoxon signed-
rank test was used to test estimated median COP and ppTRS by different methods. Table
3.5 the first column represents the method we tested, and the second column shows the p-
values of testing the difference between the estimated COP by the three methods and the
true COP location which is at 600 on the genome. The next three columns are the test of
the estimated COP locations by the paired methods. The last three columns are the test
of the posterior probabilities of true recombinant structure by each two methods. Our
result indicates that the estimated COP location for MCA method is not significantly
different from the true COP location with p-value 0.967. Although with 0.05 cutoff,
the estimated COP by the consensus method is not significantly from 600 either, the
p-value is 0.075 which is much lower than the MCA method. The COP estimated by the
exemplar method is significantly different from the true location with p-value 0.027. The
MCA COP estimates are significantly different from the CONS and EXEM estimates,
while the later two are not significantly different from each other. The EXEM method
consistently under estimate COP locations.
For estimation of true recombination structure, the difference between the consensus
method and MCA methods are not significant, but the exemplar method has a signifi-
cantly lower chance of predicting the true structure. Figure 3.5 shows that the exemplar
method fails to identify the true recombinant structure, often achieving posterior prob-
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Figure 3.5 Posterior support for true recombination structure using consensus (solid
circle) and exemplar (triangle) representative data
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COP comparison true structure
true cop CONS MCA EXEM CONS MCA EXEM
CONS 0.075 - 0.027 0.078 - 0.152 <0.001
MCA 0.967 - - 0.015 - - <0.001
EXEM 0.015 - - - - - -
Table 3.1 p-value of Wilcoxon test for consensus, exemplar, and MCA methods
Sequence diversity
high diversity medium diversity low diversity
95%-96% similar 97%-98% similar 98%-99% similar
CONS FREQ CA CONS FREQ CA CONS FREQ CA
B ≥ 10 50% 63% 98% 57% 63% 90% 44% 51% 80%
Median 95% BCI 284 312 311 392 393 399 686 665 667
MSEx104 1.3 1.4 1.8 2.8 2.5 2.8 6.9 7.0 8.4
Number 48 55 41
Table 3.2 Multiple change-point model performance with summary data type and com-
prehensive data types
abilities of the true structure well below 50%.
Table 3.5 shows the result from case study two. The frequency method and con-
ditional ancestral method have more comprehensive data types. We report proportion
of simulations with Bayes factor exceeding 10 for the hypothesis of true recombination
structure (Btrue > 10), the median difference between the upper and lower limits of the
95% Bayesian confidence interval (BCI) for the COP, the mean squared distance of the
median posterior COP from the true COP (MSE), and the number of simulations qual-
ifying in each group, where MSE and 95% BCI are calculated using only simulations
where all methods resulted in Bayes factors > 10. For all three simulation diversities,
consensus method did not do well on estimating true recombination structure for such
low diversity data. Although consensus method gives slightly better COP estimation for
the data sets with 95%− 96% similarity, as the similarity decreases the COP estimation
is worst than the other two methods. Parental data using estimated nucleotide probabil-
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Figure 3.6 Ordered median COP for case study three. The circle represents ordered
median COPs from consensus method, and the diamond represents the or-
dered median COPs from MCA method. The true COP is at position 600
(the horizontal line). The result indicates that overall MCA method gives
better COP estimation.
ities (FREQ and CA) can increase the power to detect recombination. In particular, the
power to detect the correct parents and number of COPs increases. Both comprehensive
data types have better performance, and CA method is better than frequency method
as the diversity decreases to 98%− 99%.
Simulation case three we created a situation such that consensus sequence is not
likely to represent the parental sequence, but ancestral sequence might still do well. Our
hypothesis is that under such circumstance MCA method might perform better than
consensus method. In Figure 3.6 we plot the ordered median COP locations by both
consensus and the MCA methods. It is obvious that MCA representative data provides
a better estimate of COP locations . However, the Wilcoxon test indicates the difference
between MCA method and consensus method is not significant. Figure 3.7 plots the
ordered ppTRS for both methods. The use of MCA representative data produces much
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Figure 3.7 Ordered posterior probability supporting true recombination structure for
simulation case study three. The solid circle represents the posterior proba-
bility by consensus method, and the diamond represents the posterior prob-
ability by MCA method
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higher posterior support for the correct parental genotypes with p-value < 0.002.
3.6 Discussion
For simulation case one we compared the use of consensus, exemplar, and MCA repre-
sentative data when diversity is relatively high. All methods can identify the occurrence
of recombination with high posterior support, but they differ in the ability to estimate
COP locations and parental genotypes. Although the exemplar method performed best
for a few simulated data sets, overall it gave the worst COP estimates. For many cases
exemplar method failed to identify the true recombination structures. This might be
caused by the randomly chosen representative sequences. When the representative se-
quences are close to the parental sequence, the exemplar method performs well, and can
give the best estimation in all methods. However, if the exemplar sequences are distant
from the parents it can completely fail.
The results from case study two indicates that more comprehensive data types gener-
ated by frequency and CA methods might increase the power of recombination detection
for low diversity data. In particular, the power to identify the correct parents and to
evaluate the number of COPs is increased more obviously. Under the same condition,
CA method seems to perform better than frequency method.
The Case study three indicates it is possible for consensus method performs poorly
compared to the MCA method. Under our simulation condition MCA method produce
obviously higher posterior support for the true recombination structures (Figure 3.7).
Overall the median COP estimates by the MCA method is closer to the true COP
location than using the consensus method (Figure 3.6). Therefore, there is some evidence
to indicate that the newly introduced MCA representative sequence can summarize a
genotype better than the consensus data under special situation.
Based on the result from simulation study one we believe CA would probably do the
best all-around job. However CA method involves more complicated likelihood calcula-
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tion, and is more computational expensive. Modal conditional ancestor might not be a
good estimate of ancestral sequence, except under some special case. In general consensus
works well for representing genotype. It has to be careful to use exemplar method due
to the result is likely to be biased. It is unclear whether any single sequence summary
would be better than choosing two exemplar sequences, or more. Clearly, the increased
computational burden may soon exceed any gain in accuracy. The best solution may
be adaptive MCMC that starts with many exemplar sequences. After a time, those ex-
emplars that are never nearest neighbor to the query are excluded. Exclusion continues
on and on until one or a few exemplars are left. The idea is based on the unproven
contention that phylogenetically close exemplars lead to most accurate detection.
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CHAPTER 4 RECOMBINATION STUDY IN
FULL-LENGTH HEPATITIS B VIRUS SEQUENCES
The manuscript of this work has been submitted to Molecular Biology and Evolution.
4.1 Introduction
The HBV, a member of the Hepadnaviridae family, is the cause of one of the most
frequent viral infections of humans worldwide. There are approximately 350 million
people infected with HBV in the world (Lee 1997). Chronic infection with HBV is
closely associated with fatal liver diseases such as cirrhosis and hepatocellular carcinoma
(Robinson 1994). Approximately 1 million people die of HBV-associated diseases every
year (Thomas 1993). Most of the world′s population is threatened by HBV infection.
The geographic prevalence is measured by the HBsAg carrier rate, where HBsAg are
antigenic determinants on the HBV surface. Areas of high, intermediate, and low HBV
endemicity are defined by HBsAg carrier rates more than 8%, 2-7% and less than 2%.
About 45% of the world′s population, including inhabitants of Southeast Asia, parts
of China, Sub-Saharan Africa, and the Amazon Basin, live in a high prevalence area.
Another 43%, including inhabitants of Eastern and Southern Europe, the Middle East,
Japan, and parts of South America, live in a moderate prevalence area. Only 12% live
in low prevalence areas like North America, Western Europe and Australia (Alter 2003).
HBV is a partially double-stranded DNA virus. It has the smallest genome of all
known viruses; the full-length minus-strand is about 3200 base pairs. HBV has some
unique features in addition to its strikingly small genome. Over 60% of the genome codes
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for more than one reading frame (Bollyky 1999). It is also the only known DNA virus to
replicate via an RNA intermediate using reverse transcription (Summers 1982). Like the
retroviridae family viruses, which have RNA genomes and also use reverse transcription,
HBV is highly diverse and apparently recombinogenic (Georgi-Geisberger 1992). HBV
sequences are currently classified into eight genotypes A to H based on an intergroup di-
vergence of greater than 8% for the complete genome nucleotide sequence (Norder 1994).
Recombination between HBV genotypes has been identified as a factor contributing to
the high level of diversity observed in HBV (Bollyky 1996, Georgi-Geisberger 1992, Mo-
rozov 2000). HBV genotypes have distinct geographic distributions. Genotypes B and
C are the dominant genotypes in Asian countries. Genotype A was originally prevalent
in Northern Europe, but is now found in USA, Central Africa and Asia. Genotype D is
found all over the world, genotype G is reported in North America and Europe, geno-
type F is found in Central and South America, and genotype E is only found in Africa
(Bartholomeusz 2004,Kao 2002, Minin 2005). The newest genotype H was first reported
year 2002 at Central America (Arau-Ruiz 2002).
Previous studies have shown that the prognosis of HBV patients is associated with
the identity of the infecting genotype (Chan 2003, Nakayoshi 2003, Sugauchi 2003). In
particular, there appears to be a distinct prognosis for infections caused by genotypes B
and C (Ding 2001,Kao 2000, Kobayashi 2002, Orito 2001). Studies in Japan and mainland
China found that genotype C is more commonly associated with the development of
hepatocellular carcinoma than genotype B (Ding 2001, Orito 2001). In Europe, genotype
A is associated with chronic hepatitis, while genotype D is more likely associated with
severe liver disease (Kao 2002).
While of great importance, little beyond these association studies is known about
which genotypic differences are responsible for the variable disease outcomes. In addition,
the impact of inter-genotypic recombination on disease prognosis is not well understood.
Importantly, natural recombinant sequences provide a unique opportunity to identify
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those genomic features or regions associated with poor prognosis. Indeed, Sugauchi et
al. used a natural C/B recombinant to associate genotype C with poor prognosis and
hypothesized that over expression of the protein pre-C plus core might be the cause of
the poor prognosis (Sugauchi 2002).
A number of authors have classified small groups of HBV sequences into genotypes,
and identified recombinant sequences (Bollyky 1996, Bowyer 2000, Morozov 2000, Owiredu
2001, Sugauchi 2002). Despite this effort, more than 40% of the 500 or so full-length HBV
DNA genome sequences published in GenBank have not been assigned a genotype, let
alone tested for recombination. Because the number and identity of genotypes change
with time, there are also likely to be some currently misclassified HBV sequences. Such
misclassifications have occurred with the similarly diverse human immunodeficiency virus
(HIV), and can affect inference of recombination (Gao 1998, Gao 1996).
In this study we use a Bayesian multiple change-point (DMCP) approach for re-
combination detection (Suchard 2002, Suchard 2003) to identify all the inter-genotype
recombinant sequences among 548 complete HBV genomes from GenBank. We assign
genotypes to all previously unclassified nonrecombinant sequences. For all putative re-
combinants, we estimate the location of the crossover points (COPs). We find prelimi-
nary evidence of two tentative recombination hotspots in the HBV genome. Finally we
calculate consensus sequences for HBV genotypes A, B, C, D, F, and H based on the
confirmed nonrecombinant sequences. These consensus sequences could be used to geno-
type and detect recombination in newly sequenced HBV variants and are available via
http://www.biomath.org/dormanks/hbv.
4.2 Material and method
4.2.1 Sequence alignments
We downloaded all full-length HBV sequences available in GenBank. Because the
HBV genome is circular and the subsequent analysis requires linear sequences, we lin-
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earized all sequences at the relatively conserved sequence C[CA]CCTCTGCCTA in DR1
(Jeong 2000), which is at position 1826 relative to the EcoRI site at position 1 ([CA]
indicates that either C or A is found at position 2 of this pattern). All alignments ini-
tially were generated with the ClustalW (Thompson 1994) multiple sequence alignment
software (Thompson 1994). Manual correction was used to obtain final alignments. All
location estimates are reported according to both our numbering scheme starting at the
DR1 site and the standard numbering scheme relative to the EcoRI site.
4.2.2 The model
The DMCP method used to detect recombination is a phylogenetic-based approach
that is thoroughly discussed in Suchard et al. (Suchard 2003). Recombination be-
tween distinct sequences results in topological changes in phylogenies (Owiredu 2001).
Phylogenetic-based methods attempt to detect these topological changes directly. Similarity-
based methods, e.g. Simplot (Lole 1999) and RIP (Siepel 1995), are popular recombi-
nation detection methods that examine pairwise sequence distances without reference to
phylogenies. If the most similar reference sequence changes along the genome of a query
sequence, recombination is inferred, but pairwise distances are only poor indicators of
topological neighbors in phylogenies (Koshi 2001) and may lead to false evidence of re-
combination. In addition, the DMCP approach avoids a sequential testing trap common
to most other phylogenetic detection methods, wherein the same data is used twice, first
to determine optimal recombinant structure and then again to test the statistical support
for recombination (Suchard 2002).
The DMCP model treats aligned data as consisting of an unknown number of con-
tiguous segments separated by M topology change points located at unknown positions
ξ and J evolutionary parameter change points ρ. The topology τ and the evolutionary
parameters, the transition:transversion ratio α and the average branch length µ, may
change between segments. Neighboring segments with different topologies are separated
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by a recombinant COP where the recombinant sequence shifts from one genotype to
another. Since varying evolutionary rates can lead to false evidence of recombination
(Grassly 1997), explicit allowance for evolutionary change points further lowers the false
positive rate. The current model assumes that a single, known topology relates all geno-
type sequences along the whole alignment. The putative recombinant or query sequence is
permitted to branch anywhere in this fixed genotype tree. This leads to 2G−3 topologies
possible at each position in the alignment, where is the total number of genotypes.
4.2.3 Representative parental data
There are 8 HBV genotypes, A through H, that could be involved in inter-genotype
recombination events. However, when we started this study there were only 10 full-
length genotype G sequences (21) and all of them were closely related, with an average
pairwise distance less than 1%. Similarly, there were only 4 known full-length genotype
E sequences (55), all differing by less than 1%. Because of the low representation and
homogeneity of these two genotypes, they were excluded from our analysis. Though there
were only 3 full-length genotype H sequences, the average pairwise distance was above
2% and we chose to retain this genotype.
To generate a representative sequence for each remaining genotype, we extracted all
full-length HBV sequences from GenBank that had both been treated as nonrecombinant
and assigned a specific genotype in some prior publication. Based on published reports,
epidemiologically related sequences were removed, leaving 211 total sequences. These
data were used to generate preliminary consensus sequences for each genotype. The
number of sequences used to calculate a consensus ranged from 59 for genotype C to 3
for genotype H. To verify that all 211 representative sequences were indeed nonrecombi-
nant, we tested them using the Bayesian recombination detection method. Each sequence
was profile aligned to the preliminary consensus data using ClustalW. The recombination
detection software was used to calculate the posterior probability of recombination using
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the run settings described below. Forty-two sequences with a posterior probability of
recombination larger than 0.6 were considered possible recombinant sequences and elim-
inated from the representative data. New consensus sequences were computed, and none
of the remaining 169 representative sequences exceeded the 0.6 threshold in a second test
for recombination against the updated consensus data.
For highly variable viruses like HBV, multiple variants are often purposely, and some-
times without knowledge, sampled from the same or epidemiologically related patients.
A collection of epidemiologically related clones can dominate and bias the calculation
of consensus sequences. To reduce the sampling bias, we calculated pairwise distances
using Dnadist from the free software package PHYLIP (Felsenstein 1993) under the F84
nucleotide substitution model. We randomly eliminated one sequence from all pairs of se-
quences with pairwise distance less than 0.01. The consensus sequences were recomputed
from the 139 remaining sequences and aligned to produce the final consensus alignment.
4.2.4 Detecting Recombinant Sequences
There were 379 sequences were tested in our study. In 379 sequences include 42
sequences which were used as nonrecombinants for previous studies. These 42 sequences
were tested as potential recombinant sequences. In the rest 337 sequences over half
were found without genotype information. Each sequence was profile aligned with the
final consensus alignment. All sequences with posterior probability of recombination
(see Posterior Statistics) below 0.05 were treated as nonrecombinant and assigned the
genotype having highest posterior support. All sequences with posterior probability of
recombination greater than or equal to 0.95 were considered to be recombinant sequences.
All other sequences were classified as ambiguous, neither conclusively nonrecombinant
nor conclusively recombinant.
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4.2.5 Posterior Statistics
The DMCP method produces a high dimensional joint posterior distribution over all
model parameters, including the number and location of change points, the topologies,
and the evolutionary parameters. Various summaries of the posterior distribution are
needed to present the results. Of particular value is the posterior probability of recombi-
nation, which is the probability that there is at least one COP among the change points.
For sequences with strong evidence of recombination, we also calculated summary statis-
tics regarding the genotype parentage and COP locations. We define a recombinant
structure as an ordered list of genotypes representing the parental genotype of the re-
combinant sequence reading from 5′ to 3′ along the positive strand and starting at the
transcription initiation site (example: A-C-A has two COPs). For all recombinant se-
quences, we first estimated the most probable posterior recombinant structure. Using
only the subset of the MCMC posterior sample having this modal recombinant structure,
we estimated median COP locations. A final COP location distribution was obtained by
examining all MCMC samples for matching COPs in a liberal region around this median.
When there was more than one matching COP in a sample structure, we selected the
COP closest to the previously estimated median; multiple matching COPs were infre-
quent. The posterior support for a COP is the proportion of posterior samples having
a matching COP. Reported COP point estimates are the medians of these final COP
location distributions.
Occasionally, we found COPs with high support that bordered a region with am-
biguous parentage. For example, 50% posterior support for recombinant structure C-A
accompanied by 50% support for structure D-A with a COP at the same location suggests
that the sequence is definitely recombinant, but the parent in the first region is either
C or D with equal probability. In these cases, when no parent achieved 95% posterior
probability in a region, we declined to assign a parent to the ambiguous region, denoting
the parental genotype in this region with symbol X instead.
55
4.2.6 Run Settings
The software implementing the DMCP model (Suchard 2002, Suchard 2003) simulates
an estimate of the posterior distribution using Markov Chain Monte Carlo (MCMC)
and requires that the prior distribution and several run parameters be defined. Default
priors were used, with the prior probability of recombination set to 0.5 (Sinsheimer
2003) by using w = 0.9 and λ = 5. These settings establish a prior expectation of 5
change points along the genome with 0.5 probability that at least one is a COP. The
genotype topology was set to the topology shown in Figure 4.1. This topology was
inferred from the final consensus alignment using MrBayes with the HKY85 evolutionary
model (Ronquist 2003). The posterior probability of all branches exceeded 99% and the
same tree was also given high statistical support with the less restrictive GTR model
(data not shown). The run length, subsample rate, and burnin were determined as
described in the Convergence section. All other tunable parameters were set to achieve
Metropolis-Hastings step acceptance rates around 25% (Gelman 1992) following Suchard
et al. (Sinsheimer 2003).
4.2.7 Diagnosis of Convergence
A major concern in using MCMC samples is insuring that the sample obtained is
reliable (Siepel 1995). In short, a reliable sample is one that demonstrates convergence
to the stationary distribution. To assess convergence we ran two independent chains.
Based on previous experience, we set the initial sample size to 2,000,000, the burnin to
200,000, and subsampled every 1000 steps to avoid unmanageably large posterior samples.
Three statistical tests were used to identify non-convergent samples: (Alter 2003) a test
of proportion for differences in the proportion of recombinant samples, (Arau-Ruiz 2002)
a test of proportion for differences in the proportion of samples supporting the most
likely recombinant structure, and (Bartholomeusz 2004) for recombinants, the median
test for differences in the median COP estimates. The p-values were calculated with
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Fisher Exact tests when counts for a category fell below five. In addition, we computed
the Gelman-Rubin potential scale reduction factor (Gelman 1992) for the total number
of change points and the location of each COP in recombinants. If a pair of samples
failed any one of the tests at a 0.01 significance level or produced a scale reduction factor
above 1.1, the independent chains were continued for a variable amount of time until no
test was significant. Most data sets converged after a run of length 3,800,000. A total
of 4 sequences required total run length of 5,600,000, 28 sequences required a total run
length of 7,400,000, 10 required a run length of 9,200,000, 2 sequences required a total
run length of 11,001,000, and 1 sequence required a total run length of 12,800,000. For
each sequence a combined sample of size 3600 was used to compute summaries of interest.
4.2.8 Search for Recombination Hotspots or Cold Regions
To identify recombination hotspots it is first necessary to identify COPs that appear
more than once because of viral replication and transmission. Failure to account for
COPs that are duplicates of a single crossover event will lead to false evidence of hotspots.
Currently there is no good way to identify duplicated COPs. We outline a conservative
first approach here. We identify a COP by its bounding parental genotypes, for example A
on the left, C on the right, and its location. We first categorized COPs by their bounding
parental genotypes. Then, within these categories, we clustered COPs by location based
on overlapping confidence intervals as follows. From the posterior distribution of COP
locations, we estimated 95% Bayesian confidence intervals (BCIs), then selected the two
COPs with the widest overlap in BCIs as a cluster. The location distributions of these
two COPs were merged and a new 95% BCI was obtained for the cluster. Clustering
of individual COPs and clustered COPs continued until no overlapping BCIs remained.
Location distributions for all COPs in a cluster were combined to estimate an overall
median COP location. The resulting median estimates are considered to be the COPs of
unique recombination events. We performed the analysis both excluding and including
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COPs involving the ambiguous genotype X and ancestral genotypes, where one of the
parents is the ancestor of two or more genotypes. We use the notation (YZ) to represent
the ancestor of genotypes Y and Z. To facilitate comparisons among sequences, all genome
positions were adjusted relative to reference HBV sequence NC003977, which has genome
length 3215.
To identify hotspots or cold regions we compared the distribution of unique COPs
along the genome to the distribution expected if the COPs were uniformly located. Under
the uniformity assumption, the number of COPs falling in a region of length l is given
by the Poisson distribution with rate λl, where λ = M/L is fixed given the total number
of COPs M observed in a genome of length L. Thus, we can calculate the probability
of seeing as many or more (or as few or fewer ) COPs in a window centered at genome
position c with width 2r + 1, where r is the window radius. Because we do not have a
specific region in mind prior to examining the data, we calculate a probability pcr for all
1 ≤ c ≤ 3215 and 1 ≤ r ≤ 1000. We then rank all pcr and compare the smallest ones
against an empirical distribution of minimum probabilities obtained by performing the
same procedure on 1000 datasets simulated under uniformity. Let p(i) be the ith smallest
probability calculated using the observed COPs, (c(i), r(i)) the region generating p(i), and
pˆ
(l)
j be the smallest probability for the j th simulated dataset. A p-value for region
(c(i), r(i)) is obtained by calculating the proportion of j for which p(i) is smaller than pˆ
(l)
j .
This p-value represents the probability of finding a equally hot or hotter spot (or equally
cold or colder region) than that observed assuming COPs are uniformly distributed along
the HBV genome.
4.2.9 Evolutionary Rate Variation Along the HBV Genome
We analyzed the final consensus alignment for evidence of spatial variation in evolu-
tionary parameters by applying the DMCP model without allowing topological changes
(i.e. recombination). Ten independent chains were subsampled every 2,000 cycles to pro-
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duce ten posterior samples of size 4,500. The chains were tested for convergence using
the Gelman-Rubin potential scale reduction factor on the number of change points and
the parameters α and µ at each site.
4.3 Result
4.3.1 Artificial Recombination Hotspot at DR1 Site
The HBV genome is about 3200 base pairs long and is, during some stages of repli-
cation, in a circular form. The numbering of bases for the HBV genome starts at a
unique EcoRI site located in the S gene (Bartholomeusz 2004). However, HBV genome
replication starts and ends elsewhere (Segger 2000). RNA polymerase II transcribes the
covalently closed circular DNA (cccDNA) into pregenomic RNA (pgRNA). Then using
pgRNA as the template, the HBV polymerase initiates reverse transcription to generate
nascent minus strand DNA. The reverse transcription start site is located close to the
highly conserved 5′ DR1 site at positions 1824 - 1835 relative to the EcoRI site (Segger
2000). Since most HBV sequences in Genbank are linearized at the EcoRI site, they
artificially locate the DR1 site adjacent to the opposite terminus of replication. Previous
study shows that HBV recombination might happen in a different stage of virus replica-
tion from most of retroviruses. It might happen when cccDNA transcripts into pgRNA
(Segger 2000). If recombination occurs during transcription (Segger 2000), the a priori
probability of a crossover occurring near DR1 is expected to be high, since the polymerase
has had over 3000 opportunities to switch template before crossing this artificial junction.
Previous studies have identified a recombination hotspot in the vicinity of the DR1 site
(Bowyer 2000, Morozov 2000), and we also found many crossover points (COPs) here in
a preliminary analysis of sequences linearized at the EcoRI site (data not shown). Since
the model assumes a uniform probability of recombination at all sites , it down-weights
the chance of a crossover at the DR1 site. Additionally, if recombination is associated
exclusively RNA transcription, inference of a COP at the DR1 site does not imply a
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true strand switch event. To avoid this potential problem, we rearranged all full-length
sequences to start at position 1825, where the polymerase initiates transcription.
4.3.2 Constructing Representative Parental Data
Successful identification of a recombinant sequence depends on a well-constructed
set of comparison sequences. In particular, the set must include at least one sequence
representing all parental sequences involved in the recombination event. Since we are
looking for inter-genotype recombinants, we should include a representative sequence
of each genotype. In addition, because there is much within-genotype variability (the
average within-genotype pairwise distance is 0.04), the representative sequence should
be a fair summary of the genotype. For example, a single, representative sequence se-
lected randomly performs poorly, while the inferred ancestral or consensus sequence of a
representative sample of sequences works best (Sinsheimer 2003, Fang, unpublished dis-
sertation). Finally, the representative data should not include misclassified recombinant
sequences since recombinant signal in the parents would contradict the assumption of a
fixed parental tree and could result in false positives for recombination (Salminen 1997,
Fang, unpublished dissertation). We found 211 HBV full-length sequences that had been
used as nonrecombinant genotypes in previous studies or reported as nonrecombinants.
These sequences were used to compute a preliminary consensus sequence representing
each genotype. All 211 were individually screened for recombination against the con-
sensus sequences, as described in the methods, and considered possible recombinants if
the posterior support of recombination was greater than 0.6. We identified 42 possible
recombinant sequences; they did not constitute a majority within any genotype. The
remaining 169 sequences were used to calculate new consensus sequences and remained
consistently negative for recombination in a repeat analysis with the new consensus se-
quences. Although we attempted to eliminate epidemiologically linked sequences in the
first step, our literature search may still have failed to detect some very closely related
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sequences, such as sequences from the same patient or transmission patient pairs. We
screened each genotype for exceptionally similar pairs of sequences as described in the
methods. We assume that pairs of sequences with a distance less than 0.01 are likely
to be epidemiologically related and therefore do not represent a fair sample of HBV
infections. Forty-three sequences were eliminated in this final step, leaving 126 nonre-
combinant, representative sequences, 19 sequences for genotype A, 25 for B, 56 for C, 16
for D, 7 for F, and 3 for H. An alignment of these final consensus sequences is available
at http://www.biomath.org/dormanks/hbv.
4.3.3 Misclassified Sequences
Of the 42 sequences identified as potentially recombinant during the first screen of
representative data, 33 sequences still supported recombination, with posterior proba-
bility of recombination over 0.6, when compared against the final consensus alignment
(Table 4.3.3). The posterior support for recombination was not always high, indicating
that some of these sequences are simply ambiguously classified. In addition, the five
recombination events involving parent (FH), that is the ancestor of genotypes F and H,
are difficult to interpret, especially X75663 where (FH) is indicated to have recombined
with genotype F. The (FH) regions may represent segments of the sequence that are am-
biguous, unclassified, or related to a genotype not included in the analysis. Persistently
unclassified regions exist in several HIV circulating recombinant forms (Page). The re-
combinant involving ancestral genotype (AB) is equally difficult to interpret, but appears
more than once in our dataset (see Figure 4.2) and will be discussed again later.
4.3.4 Recombination Prevalence in HBV
Of the 379 sequences previously identified as recombinant or of previously unknown
genotype, 142 (38%) were confirmed or found to be recombinant with posterior probabil-
ity of recombination above 0.95. Another 161 (58%) sequences are strongly nonrecom-
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Figure 4.1 Fixed parental topology relating the genotype consensus sequences. This
tree was inferred use MrBayes and HKY85 model of nucleotide substitution.
The posterior support for each branch exceeded 99.9%.
Figure 4.2 HBV Circulating recombinant forms. Vertical bars indicate posterior median
crossover point locations and shaded regions report 95% Bayesian credible
intevals
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Genotypes # of Sequences Used in
Representative Data
# of Newly Identi-
fied Sequences
Total
A 19 37 56(20%)
B 26 4 29 (10%)
C 56 94 150(50%)
D 16 20 36(13%)
F 7 3 10(3%)
H 3 3 6(2%)
Total 126 161 287
Table 4.1 Genotype statistics for nonrecombinant sequences.
binant (posterior probability of recombination less than 0.05). These nonrecombinants
consist of 23% (37) genotype A, 3% (4) genotype B, 58% (94) genotype C, 12% (20)
genotype D, 2% (3) genotype F, and 2% (3) genotype H. Results for the remaining 73
sequences were ambiguous, though most showed little evidence of recombination (poste-
rior probability less than 0.5). Only 13 sequences have borderline posterior support for
recombination in the range (0.60, 0.95); they are referred to as ambiguous recombinants
T. More than half of the recombinants have a single COP (68%), while 8 (6%) have two
COPs, and 17 (6%) have more than two and as many as six COPs. In tabulating these
numbers, we have excluded COPs with less than 95% posterior support; 42% of the 263
COPs are excluded by this criterion. Most of the unsupported COPs appear as nearby
pairs with a short, ambiguous region separating them. For example, the recombinant
structure C-A-B, with genotype A covering the region 400 to 650, is frequently observed
(Figure 4.2). While parental regions C and B are highly supported, A is ambiguously
supported, indicating that at least one COP, and perhaps two, appear in region 400-
650 with high probability. Considering all results, the analyses indicated that 28% of
all full-length HBV sequences published in GenBank represent inter-genotype recombi-
nants. Because genotypes are not homogeneously distributed around the world, certain
combinations of genotypes in recombinants are expected to be more common than oth-
ers. Of all recombinants, 20% involve genotypes A and D, 69% involve B and C, 4%
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Genotypes # of Recombinants∗ # of Excluding Repeart
CRFs%
B/C 98(69%) 6(22%)
A/D 28(20%) 12(44%)
C/D 6(4%) 4(15%)
A/C 2(1%) 1(4%)
A/C/(AB) 2(1%) 1(4%)
A/(FH) 1(<1%) 1(4%)
F/(FH) 2(1%) 1(4%)
F/H 1(<1%) 1(4%)
involving X 2(1%)
Total 142 27
Table 4.2 Genotype involved in recombinant events: ∗ Recombinants for whom a second
parental genotype is not clearly identified, i.e. those involving the ambiguous
parent X with one other genotype, are listed in the last row. Recombinants
with two or more genotypes supported at >0.95 posterior support are listed
under the corresponding row, and regions with ambiguous parentage are ig-
nored. % Sequences are clustered into CRFs if they have the same recombi-
nant structure and all COPs have overlapping Bayesian confidence intervals.
Parent support need not exceed 0.95 posterior probability in each region to
cluster in a CRF. There were nine sequences clustered into four distinct CRFs
that did not have >0.95 posterior parent support in one region. Most of these
are listed in Figure 2 and discussed elsewhere.
involve C and D, and the remaining 7% involve other combinations of genotypes (Table
4.3.4). Five recombinants involve ancestral genotypes, which are the ancestors of two
or more genotypes. Ancestral genotype (FH) is involved in three, and (AB) is involved
in another two. These latter three sequences are also the only recombinants involving
three distinct genotypes, with A and C joining (AB) as parents. Parental sequences not
achieving high support somewhere along the sequence alignment were not included in
the preceding analysis.
Of the non-recombinants, we identified three new genotype H sequences (AB064315,
AB059659, AB059660) and one new F genotype sequences (AY311369). Accession AY311370
is another likely genotype F sequence that just misses the 0.05 cut-off for highly sup-
ported nonrecombinants (posterior probability of recombination 0.051). Another possible
64
F sequence (AB086397) was isolated from a Japanese patient. This sequence is somewhat
ambiguous, with posterior probability of recombination 25%, but it could represent the
first genotype F found in Asia.
4.3.5 Circulating Recombinant Forms
Many recombinants appear to share the same recombinant structure and could reflect
the transmission and expansion of a single, founding recombinant virus. These so-called
circulating recombinant forms (CRFs) are common in HIV (Robertson, 1995a, Robertson,
2000). Formally, an HIV recombinant may be called a CRF once it has been isolated
from three distinct patients (Peeter 2000). Sugauchi et al. (Sugauchi 2002) previously
identified a C-B recombinant circulating in Asia. They reported 41 sequences with nearly
identical recombinant structure. We confirmed those results and found that 85 (90%)
of all recombinants involving genotypes B and C share this identical C-B structure. In
addition, we found nine other sets of sequences that may be previously unreported CRFs.
The common C-B CRF and three other potential CRFs are reported in Figure 4.2.
The other six potential CRFs are A/D recombinants and are presented along with the
A/D recombinants in Figure 4.3. In both figures the HBV genome is shown linearized
at the DR1 transcription start site. Posterior median COP estimates are indicated with
vertical lines and 95% Bayesian confidence intervals for the COP locations are shaded
gray. We traced four C-B-C-B recombinant sequences with similar COP locations to four
Indonesian patients (accession numbers AB033554, AB033555, D00331, and M54923),
however neither the second C-like region nor the COPs that bound it are highly supported
in any of these sequences. Removing the second region leaves the familiar C-B structure
identified above. We could trace one of the three sequences sharing the C-A-B structure
to a patient in Japan (AJ131133) and another to a patient in Thailand (AB073830),
but the A region and bounding COPs are not highly supported, leaving a structure
again similar to the C-B CRF. Two sequences (AF241407, AF241409) sharing the C-A-
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Figure 4.3 HBV A/D recombinants. Black regions A indicate referred percentage her-
itage, white regions D inferred percentage heritage, and grey portions report
95% Bayesian credible confident intevals on the crossover points between
regions. Vertical bars locate median posterior crossover point estimates.
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(AB) structure are from different patients, making this structure involving an ancestral
genotype another possible CRF. However, since the (AB) ancestor by definition cannot
coexist in time with the A genotype, the (AB) region ancestry is unclear, and this region
may descend from a genotype not included in our analysis.
Six patterns of A/D recombination were each identified in at least two patients. Each
pattern is reported along with other A/D recombinants in Figure 4.3, where genotype
A regions are white and genotype D regions are black. Accession numbers AF418690,
AF418691, AF418692 and AY161147 were isolated from two patients and share structure
A-D-A-D-A-D-A-D, though the first and last D-like regions are short and only weakly
supported. AF418690 through AF418692 share virtually identical structure and were all
isolated from the same patient. Of these three sequences, only AF418690 is diagrammed
in Figure 4.3, and is labeled AF418690 (Bartholomeusz 1996) to indicate there are three
sequences from the same patient with this structure. This structure is similar to a
second A/D recombinant found in another six strains (AF418684, AF418687, AF418688,
AF418689, AY161148 and AY161149) isolated from the same two patients. This set of
sequences, however, has a narrower second D region and an extra D region, making this
structure the most complex recombinant structure in our data set. Again, out of these six
strains, only AF418684 and AY161148, from different patients, are presented in Figure
4.3. Another 12 A/D recombinants have less complex structures. Four (AF418674,
AF418675, AY161140, AY161141), isolated from two patients, have a D-A-D structure,
and another four (AF418682, AF418683, AY161145, AY161146), isolated from another
two patients, have an overlapping, but distinct D-A structure (Figure 4.3). Two sequences
from different patients (AF297619 and AF29620) have an A-D-A structure, and another
two sequences (AY161161 and AF418681) from another two patients share a distinct
D-A-D structure.
If we count each group of CRFs only once, the distribution of genotype mixtures con-
tributing to HBV recombination changes. In particular, the frequency of recombination
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between genotypes B and C is sharply reduced after eliminating copies of the widespread
C-B variant (Robertson 1995a). Assuming a total of nine possible CRFs, the corrected
numbers are reported in the last column of Table 4.3.4 and should better reflect the
actual frequency of recombination between different genotypes.
4.3.6 Recombinants Involving A and D Parental Genotypes
In this current study we identified 28 recombinants involving parental genotypes A
and D (Figure 4.3). The 28 sequences were isolated from 18 patients from India, Africa,
Greece and Italy. As discussed above, A/D recombinants tend to be particularly complex.
In addition to the A/D CRFs that were found in multiple patients, we also found some
patients with more than one A/D recombinant structure. Accessions AF418684 through
AF418692 were isolated from the same patient and include four different A/D recombi-
nant structures. Sequence AF418686 is distinguished from the AF418684 CRF (Figure
4.3) by a significantly different location for the eighth COP, while sequence AF418685
is missing the third D region. It is possible that the missing D region in AF418685
represents a failure of the MCMC sampler to converge. To help reject this possibility,
we tried initiating the sampler with the extra D region, but still inferred the same, sim-
pler structure. Accessions AY161147 through AY161149 were also isolated from a single
patient and include two distinct A/D recombinant structures. Finally, we identified a
patient infected with both recombinant A/D and nonrecombinant sequences. The three
sequences AF418679, AF418680 and AF418681 were isolated from the same patient, but
the first two sequences are nonrecombinant genotype D and the last is shown in Figure
4.3 as a D-A-D recombinant with 0.98 posterior support.
4.3.7 Tentative Recombination Hotspots
In order to identify hotspots for viral recombination or regions that appear to pro-
mote multiple, independent recombination events, it is important to exclude COPs that
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have been duplicated and transmitted through natural viral replication and transmission.
However, a truly efficient hotspot will generate multiple similar-appearing COPs, and we
currently have no way to distinguish these alternate causes. As a consequence, we took
a conservative approach and identified only those COPs virtually certain to be the re-
sult of independent strand switching events. Clearly, COPs involving different genotypes
are unique. When two COPs share the same neighboring (left and right) genotype, we
compared COP locations to determine if the COPs represent unique events. Statisti-
cally indistinguishable COPs were clustered as described in the methods. The combined
posterior sample of all COPs in a cluster was used to estimate an overall median COP
location to represent that cluster.
We found a total of 27 unique COP clusters that we can safely assume are the result
of independent recombination events. Twenty (74%) of the 27 clusters contain only one
member. The median COP location estimates of all 27 clusters are plotted as small,
solid-filled circles on a map of the HBV genome in Figure 4.4. COPs are present
throughout the genome, and there is only weak evidence of hotspots and no evidence of
cold spots. The cluster of COPs at position 661 has the smallest p-value of 0.09. If COPs
bordered by ancestral parents (FH) or (AB) are included in the analysis (grey circles),
the cluster centered at 394 has the smallest p-value of 0.06. Finally, if COPs bounded by
ambiguous parent X (open circle) are considered, we identify 1 potential hotspot centered
at 397 with p-value less than 0.05.
4.3.8 Evolutionary Rate Variation Along the HBV Genome
One of the major advantages of the Bayesian model used here to infer recombination is
that it simultaneously accommodates spatial variation in other evolutionary parameters.
Failure to allow spatial variation can lead to false inference of recombination (Suchard
2002). Because the HBV genome is compact, with numerous overlapping reading frames,
we suspect that there is striking variation in the evolutionary rate throughout the full
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Figure 4.4 Genomic distribution of crossover point locations. Posterior medican
crossover point locations are indicated by small circles around the outer
circumference of this diagram of the covalently closed circular form of the
HBV genome. Solid circles are crossover points with >95% posterior sup-
port. Grey circles are crossover point with >95% posterior supprot where
one parent is an ancestral genotype (see text). Open circles are crossover
points >95% posterior support and ambiguous parentage (see text). The lo-
cation of open reading frames and protein products are drawn and labeled.
Numbering of gene boundaries relative to the EcoRI site (upper triangle)
and numbering relative to the transcription initiation site (lower triangle)
are labeled inside and outside the inner circle, respectively.
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genome. To analyze the spatial variation, we applied the DMCP model while assuming
a single fixed topology (Figure 4.1) to the final consensus alignment. While consensus
sequences show less variation than actual HBV sequences, the same patterns of spatial
variation should apply. The scale reduction factor for the number of change points
was 1.015, indicating good convergence. Scale reduction factors were also computed for
parameters α and µ at each site along the genome. All but the last 13 base pairs of the
alignment showed good convergence with a scale below 1.1. The properties of the ends of
an alignment are traditionally inferred with less precision, and the maximum scale factor
in the 3 R region was 1.18. A summary plot of the marginal posterior distribution of
µ, the average branch length, at each position along the alignment is shown in Figure
4.5. Significant shifts in evolutionary rates are observed, but not always near gene
or overlapping reading frame boundaries as we had anticipated. The gene C/pol overlap
region is more conserved, but the portion of pol overlapping with preS1 and preS2 is no
more conserved than the non-overlapping regions. Also, only a small portion of the 3 R
non-overlapping segment of the pol gene experiences an increased rate of evolution. The
predominantly low divergence suggests selection in this region. Though the function of
gene X is unknown, the evolutionary rate for this region is quite low even where it does
not overlap with 3′pol. There were no significant changes in the transition/transversion
rate α ratio along the genome.
4.4 Discussion
Currently there is not enough experimental evidence for HBV recombination between
different hepadnaviruses under controlled experimental conditions. All of our studies
were based on published sequences. Previous study shows that recombination could
be generated in vitro as a result of the experiment for sequencing, such as PCR. It
is impossible using our method to identify which recombinant sequences published on
GenBank are fake recombinants generated in vitro during PCR, not viruses themselves.
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However, our analysis is valid because of the following reasons. First it has been well
known that DNA viruses are not as recombinogenic as RNA viruses. HBV is the only
well known DNA virus with high diversity and having recombination. There are many
DNA viruses have been full-length sequenced and have not been found recombination. So
if the sequencing technique causes most of the recombinant sequences we should observe
recombination in most of virus sequences. Second, we reanalyzed some of the sequences
which have been published as recombinant sequences in previous study. Over 90% of
our results are consistent with the previous study on the recombinant genotypes. This
proves our method is consistent and reliable.
Base on the above argument we tested 379 HBV sequences, all full-length HBV se-
quences found in GenBank as of February 2004, for inter-genotype recombination. One
hundred and forty-two sequences (38%) were identified as recombinants (>95% posterior
support for recombination), and 37% of these had been previously reported. Another
161 sequences (42%) were nonrecombinant (< 5% posterior support for recombination),
and our method assigned 86 (54%) previously unassigned sequences to specific genotypes.
Finally, 73 (19%) sequences were classified as ambiguous, with posterior support for re-
combination between 5% and 95%. We could not confirm the nonrecombinant status of
32 sequences previously misclassified as nonrecombinants or used as nonrecombinants in
phylogenetic studies (Table 4.4).
Recombinants usually had a simple structure with the majority (73%) displaying only
a single COP. The remaining recombinants had two COPs (15%) and three or more COPs
(12%). In addition, 94% involved just two genotypes, while 6% involved three genotypes.
We chose to linearize the HBV genome at the transcription initiation site rather than
the usual unique EcoRI site. If recombination occurs during reverse transcription or
RNA transcription and the genome is linearized at the EcoRI site, then we would expect
to find false evidence of crossover events at the initiation site, interfering with hotspot
identification. In addition, if there were a true hotspot near the EcoRI site, it would
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be likely missed because the method loses power to detect recombination events near
alignment termini. Finally, if recombination occurs when the virus is in a circular form,
then no linearization is appropriate and the DMCP method would need to be modified
slightly to work with circular sequences.
A major advantage of the model used here to infer recombination is its ability to
accommodate spatial variation in the evolutionary process along the genome (Suchard
2003). We analyzed the final consensus alignment for evidence of spatial variation and
found significant variation in the evolutionary rate. Not surprisingly, there was increased
conservation in the overlapping reading frames, though the preS1 and preS2 regions of
the S gene were less conserved despite their overlap with pol. Perhaps strong immune se-
lection maintains variation in preS1 and preS2 (Usuda 1999,Usuda 2000), and this region
of pol is especially tolerant. In addition, the X gene was highly conserved throughout
its length despite only partial overlap with the pol gene. Although the exact function
of X gene is not very clear the genomic conservation of this region probably reflects the
functional importance of X gene.
Recombinant sequences that subsequently spread through populations have been
called CRFs in the HIV literature (Robertson 2000, Robertson 1995a). A CRF involving
genotypes B and C has been previously identified in (Sugauchi 2002). Here we report
up to nine new potential circulating recombinant forms. Many involve recombination
between genotypes A and D with a variety of complex structures. Some of these A/D
structures and the two distinct B/C structures show partial overlap, such that some
COPs appear to be shared, while others are statistically distinguishable. These patterns
are typical of repeated recombination events involving previously recombined strains
(Salminen 1997), but further study is needed to determine whether single or multiple
recombination events produced these recombinants.
HBV genotypes are not uniformly distributed around the world, and we expect cer-
tain combinations of genotypes to occur more frequently than others in recombinant
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sequences. Genotypes F and H are known to co-circulate in the high endemicity areas
of Central and South America, but we found only one F/H recombinant in our dataset.
Nevertheless, one recombinant in a total of only 16 available F and H sequences could
indicate a high frequency of F/H recombination (more frequent than C/D recombination,
for example). Most HBV recombination in the world, though, appears to happen in Asia.
Genotypes A, B, C, and D are known to circulate in Asia (Bartholomeusz 2004), and
we found plenty of evidence of recombination among B/C and A/D genotypes, but fewer
A/C and C/D recombinants, and virtually no evidence of A/B and B/D recombination.
Recombinants involving genotypes B and C, including one or two CRFs, are frequently
found in Southeast Asia, where both genotypes co-circulate in a high endemicity area.
We also found many A/D recombinants, including several potential CRFs, from patients
in India where D is prevalent and A was recently isolated (Sugauchi 2004). If geno-
type B and C sequences are confined to Southeast Asia, while A and D to Northwest
Asia, then one would expect a lower prevalence of A/B, A/C, B/C, and C/D recombi-
nants. However, these genotypes are not completely isolated in Asia. We identify an A/C
recombinant (AY057947) in a patient from Tibet that along with another C/D recombi-
nant (AY057948) from Tibet (Cui 2002), suggestint that Tibet may server as a mixing
ground for the HBV genotypes of Southeast and Northwest Asia. But Tibet is not the
only source of these recombinants in Asia. Three sequences (AF241407, AF241408, and
AF241409) were isolated from Vietnamese patients and represent the putative CRF with
structure C-A-(AB) (Figure 4.2), where (AB) is the ancestral genotype of genotypes A
and B. There is > 99% posterior support for the parents C and A in the first two re-
gions. Other C/D recombinants include AF473543 and AF461043; these sequences lack
patient information but were submitted to Genbank from China. A/B and B/D recom-
bination only appeared with low statistical support in our analysis. Sequence AB073830
was isolated from a Thai patient, AJ131133 from a Japanese patient, and along with
sequence AF479684 with no patient information, may involve recombination among the
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three genotypes A, B, and C (Figure 4.2), although the support for the A-like region is
weak. There were two similar C-B-D recombinant structures in our dataset (AB031265
from a Vietnamese patient and AB073825 from a Chinese patient), but the D-region is
confined to the last 100 nucleotides of the genome and has less than 60% posterior sup-
port in both cases. If any of the A/C or C/D sequences isolated from Southeast Asian
patients also recombined in Southeast Asia, then it is probable that genotypes A and D
are circulating somewhere in Southeast Asia, but perhaps outside the range of genotype
B.
Owiredu et al. showed that asymptomatic black African carriers of HBV with negative
serum HBsAg may still develop hepatocellular carcinoma (Owiredu 2001). Two sequences
(AF297619 and AF297620) from their study were reported as A/D recombinants. Our
results confirm these two sequences have structure A-D-A. Interestingly, we found two
Italian patients with A/D recombinants and 14 Indian patients with A/D recombinants
also reported to be HBsAg negative with chronic liver disease. It is not clear whether
A/D recombination contributes to the observed disease course, but if it does, careful
examination of the recombinant structures may lead to hypotheses about which genomic
regions play a role.
Our study identifies two tentative recombination hotspots and no recombination cold
regions along the HBV genome. The potential hotspots are located around positions 400
(2225 relative to the EcoRI site) and 660 (2485). Sites 400 and 660 bound the overlap
region of genes C and P. It is possible that these sites represent only one hotspot, since
COP location distributions in this region often displayed bimodal or highly skewed pos-
terior distributions, with the distributions of 83 (61%) of 136 COPs and 4 (36%) of 11
unique COP clusters located in this region covering both positions 400 and 660. It is
also possible that the boundaries of the highly conserved overlap region are statistically
attracting nearby COPs and leading to artificial evidence of a hotspot (Owiredu 2001).
Previous studies have pinpointed the DR1 site, the end of the core gene, and the 3′ end
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of the S gene as rich in COPs (Morozov 2000). We tentatively confirm a hotspot at the
end of the core gene, but cannot confirm a hotspot in the 3′ end of the S gene. Since
we linearize the genome at the DR1 site, we are unable to detect even a true hotspot
in its vicinity. We caution, however, that a hotspot here may be an artifact of the fact
that transcription initiates nearby. While we found no strong evidence of hotspots, it is
important to remember that our approach to hotspot detection is very conservative. To
detect hotspots, it is necessary to eliminate COPs in the data set that result from the
replication and transmission of a single crossover event. Since no methods exist to distin-
guish single vs. multiple recombination events, we simply assumed that all COPs with
the same neighboring parents and similar locations descended from the same recombina-
tion event. Preliminary work suggests that the widespread C-B recombinant circulating
in Asia is the product of at least two distinct recombination events (Fang, unpublished
dissertation). Since this circulating recombinant form has a COP at position 400 (EcoRI-
relative: 2225), the p-value in support of the hotspot in the C gene should be adjusted
downward. It is plausible that these and other locations would appear as hotspots in the
HBV genome with strong support if we could distinguish multiple recombination events
from the replication and transmission of single recombination events.
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Figure 4.5 Varying evolutionary rate (µ) along HBV full-length genome. The final
consensus alignment was analyzed for variation in evolutionary parameters
along the HBV genome. The top plot maps the gene locations along an
alignment which starts at the transcription start site near DR1. The solid
line on the bottom plot is the marginal posterior median of the expected
average branch length µ, and the dashed lines indicate the 95% Bayesian
credible intevals.
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Accession Reported Geno-
type
Posterior Prob. of Re-
combination
Recombination
Status
AF297621 A 0.99 (FH)-A
U87742 A 0.91 A-(FH)-A
AB033555 B >0.99 C-B-C-B
AJ131133 B > 0.99 C-A-B
AB033554 B > 0.99 C-B-C-B
AF461360 B > 0.99 C-B
AF282917 B > 0.99 C-B
AF282918 B > 0.99 C-B
AY206373 B > 0.99 C-B
AY206380 B > 0.99 C-B
AY206383 B > 0.99 C-B
AY206375 B > 0.99 C-B
AY206377 B > 0.99 C-B
AY206391 B > 0.99 C-B
AY206390 B > 0.99 C-B
X98072 B > 0.99 C-B
X98077 B > 0.99 C-B
X75656 B > 0.99 C-D
AF282918 B > 0.99 C-B
AF241407 C 0.99 C-A-(AB)
Y18857 C 0.71 C-B
AB048704 C 0.99 C-D
D16665 C > 0.99 B-C
X75665 C 0.99 C-D
X80925 D 0.74 D-A
X65258 D > 0.99 A-D-A-D-A
X68292 D 0.99 A-D-A-D-A-D-A
X75658 D > 0.99 (FH)-F-A
X65259 D > 0.99 D-A
AF043594 D 0.81 C-D
AB033558 D 0.80 (FH)-D
X75663 F > 0.99 (FH)-F
Table 4.3 Misclassified sequences.
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CHAPTER 5 A BAYESIAN PHYLOGENETIC MODEL
FOR COUNTING RECOMBINATION EVENT
The work in this chapter has been published at: A Bayesian phylogenetic model for
counting recombination event. (JSM), Minneapolis, USA, Augest 2005.
5.1 Introduction
Recombination is a common phenomenon in viruses that generates novel genetic mo-
saics with potentially important phenotypes. In vitro and in vivo biological experi-
ments have provided solid evidence for the occurrence of virus recombination (Kottier
1995). Recombination has been found in many high diversity viruses (Field 1982, Carr
2001, Worobey 2001, Webster 1997). For example, most retroviruses, such as HIV, have
high recombination frequencies (Clavel 1989, Katz 1990). This is probably because the
virally-encoded reverse transcriptase, an enzyme catalyzing the formation of DNA from
an RNA template, is highly recombinogenic (Hu 1990). Recombination has also been
identified in DNA viruses such as hepatitis B virus (HBV) (Bollyky 1996, Fang 2005).
Because genetic recombination generates novel offspring with large genetic changes from
the parental strains recombination provides viruses a chance to evolve faster and to adapt
environmental conditions better (Felsenstein 1974). Many studies have shown that re-
combination is related to several medical concerns including virulence (Liitsola 1998),
drug resistance (Kellam 1995), vaccine development (Korber 2001), and probably virus
co-species transmission (Rest 2003).
Much effort has focused on understanding the mechanism of virus recombination
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(Zhang 1993, Stuhmann 1992) through experimental approaches. Some have hypothe-
sized that specific primary sequence or RNA secondary structure can promote recombi-
nation at particular sites along the genome (Kohli 1999, Moumen 2001, Galetto 2004).
For example, recombination sites cluster within or close to AU-rich regions in brome
mosaic bromovirus (BMV) (Nagy 1997) and in vitro copy-choice recombination rates are
high at several sites along the HIV-1 genome, including the R sequence (Moumen 2001).
It may also be possible to deduce information about the mechanism of recombination
by studying naturally occurring recombinant sequences. Although selection and evolution
dilute sequence or structure signals that promote recombination, in vivo hotspots should
be enriched for such signals when they exist. In highly recombinogenic viruses, it has
been possible to identify in vivo hotspots. Recombination occurs more frequently near
the dimerization initiation sequence during HIV-1 replication (Dykes 2004). Another
potential recombination hotspot of HIV may be located at certain regions, such as partial
reverse transcriptase (RT), vif/vpr, the first exons of tat/rev, vpu and gp41 (Magiorkinis
et al. 2003). Preliminary evidence suggests a recombination hotspots in HBV C gene
(Fang 2005).
Identification of in vivo hotspots relies on the ability to detect historical recombi-
nation events. Since recombination is easiest to detect when the recombining parents
are genetically divergent, recombinants between different viral subspecies, called geno-
types, are most often studied. Two recombinant sequences with recombination crossover
points (COPs) located at the same position along a genome may be the consequence
of a recombination hotspot. When the sequences are recombinants involving different
parental genotypes, they are obviously the product of separate recombination events.
It is common, however, to observe multiple recombinant sequences with the same COP
locations and the same parental genotypes (Sugauchi 2002, Fang 2005). The conserva-
tive assumption is that these recombinants descend from a single event that spread by
chance or selection (Robertson 2003,Fang 2005). However it is also possible, particu-
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larly when hotspots exist, that multiple, similar recombination events produced nearly
identical mosaic structures (Fang 2005).
Here, we report a Bayesian phylogenetic-based method for identifying multiple re-
combination events from two or more putative recombinant sequences with similar re-
combination structure. Our method is based on a dual multiple change-point (DMCP)
recombination detection model (Minin 2005). Although the DMCP model can detect
recombinant sequences accurately, it is not designed to identify recombination events.
The DMCP model currently analyzes only one putative recombinant sequence. While
it is possible to modify it to analyze multiple recombinant sequences simultaneously, it
is impossible, using the current priors, to place appropriate prior probabilities on single
vs. multiple recombination events. We define a novel prior that controls the probability
of recombinational events. We test our methodology on simulated data, then apply it
to a set of six HBV recombinants with similar mosaic structure and reveal two unique,
underlying recombination events.
5.2 Methods
5.2.1 The phylogeny of recombination events
A molecular phylogeny summarizes the relationships between species or organisms by
comparing genetic information coded in DNA or RNA sequences. We examine the phylo-
genetic relationship of multiple recombinants by aligning them to nonrecombinant geno-
type sequences representing possible parental genotypes. We borrow the terms monophyly
and polyphyly from general molecular phylogenetics to characterize the resulting phylo-
genies. Given an ancestral sequence in the phylogeny, a monophyletic group consists
exclusively of all the ancestor’s descendents. A polyphyletic group includes descendents
of other ancestors or excludes some descendents of the ancestor. In our model, the term
monophyly is used to describe trees where all the recombinants form a monophyletic
group. If the group of recombinants is disrupted by representative sequences the trees
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are polyphyletic.
Monophyly is consistent with either single or multiple recombination events, and poly-
phyly can only imply multiple events. We use an example to demonstrate the argument.
Let C1 and B1 be representative sequences for genotypes C and B. Suppose q1 and q2
are two sequences that share a COP where their genotype switches from C to B. Figure
5.1 shows the evolutionary relationships between the recombinants and representative
sequences for the portion of the genome where both recombinants belong to genotype
C. In Figure 5.1(a), q1 and q2 are polyphyletic. It is obvious that two distinct parents
produced the recombinants, and thus there were two distinct recombination events. In
Figure 5.1(b) another possible phylogeny is displayed where the two recombinants are
monophyletic. Unfortunately, given the current reference sequences, it is impossible to
determine how many recombination events occurred in Figure 5.1(b).
5.2.2 Choosing representative data
The choice of representative genotype sequences determines whether multiple recom-
bination events can be detected. If representative sequence C1 is unable to confirm that
the recombinants in Figure 5.1(b) resulted from two events, then another choice of repre-
sentative C sequence, e.g. C2 in Figure 5.1(c), may be able to resolve the events. Thus,
including more representative sequences can increase the chance of detecting multiple
Figure 5.1 Polyphyletic and monophyletic recombinants. Compared to reference geno-
type sequences C1 and B1, the recombinant sequences q1 and q2 are (a)
polyphyletic indicating they were from different recombination events, or
(b) monophyletic, indicating either one or two recombination events. (c) In
the second case, if another representative sequence C2 is added, it may be
possible to establish that there were two recombination events.
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recombination events when they exist. Unfortunately, both computational difficulty and
statistical uncertainty rise rapidly as more representative sequences are included. In
recombination detection, a collection of aligned representative sequences is summarized
most commonly by a single consensus sequence consisting of the majority nucleotide
at each position. However, the consensus sequence is not a real sequence and since the
branching order completely determines monophyly vs. polyphyly, the consensus sequence
cannot be used to identify recombination events. Instead, we select a limited number of
nonrecombinant, exemplar sequences to represent each genotype.
While the number of exemplars per genotype may be limited by computational bur-
den, exemplars can be selected to increase the chance of detecting multiple events. Con-
sider Figure 5.2, where the phylogenetic relationships of five exemplars for genotype C are
shown. Let two polyphyletic recombinant sequences descend from the ancestors marked
by circles on the tree. Polyphyly can be detected with fewer representative sequences as
long as at least one descendent of the more ancient of the two ancestors, i.e. at least one
of C2, C3, or C4, is selected.
Generally the recombinant branch points will not be known prior to the analysis.
In this case, a simplistic strategy is to select exemplars that cover as much of the tree
structure as possible. Given a topology as in Figure 5.2, we select one exemplar from each
of the two subclades of the root, i.e. select one from {C1, C2, C3, C4} and one from {C5}.
When recombinant branch points are distributed randomly in the genotype tree, this
strategy is the most likely to detect polyphyly. In Figure 5.2, given sufficient statistical
Figure 5.2 Selecting representative genotype sequences. C1, . . . , C5 are genotype C
non-recombinant sequences. The filled circles represent the most recent an-
cestors of two parents involved in separate recombination events.
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power to resolve phylogenies, this strategy would to detect polyphyly 75% of the time.
A second benefit of the strategy is that it can be applied recursively. If, for example C1
and C5 are selected, the recombinants would appear as monophyletic, closest neighbors
of C1. A recursive analysis could now select two sequences, one each from the two clades,
{C1} and {C2, C3, C4}. Assuming the correct phylogeny is inferred, there is now a 100%
chance to detect polyphyletic recombinants.
The recursive strategy outlined above relies on a properly rooted genotype tree. We
root genotype trees by included one exemplar sequence from another genotype, but it
is worth noting that rooting is notoriously error-prone. Other taxon-sampling strategies
are possible, but we attempt no thorough analysis of this problem here.
5.2.3 Choices of recombinant sequences
Before we can test for multiple recombination events, it is necessary to identify a group
of recombinants with identical recombinant structure. Any method that can identify
recombinants, including the parental genotypes and crossover point locations, can be
used to find groups.
In some cases there may be many more recombinants with the same structure than
can be feasibly included in the analysis. If these recombinants result from multiple
events, then the descendents of each event should form separate clades in a phylogenetic
tree. Thus, to choose recombinants, we align all recombinants, infer a phylogenetic tree
with statistical support (e.g. bootstrap support or posterior branch probabilities), and
randomly select one recombinant from some or all of the statistically supported clades.
5.2.4 Multiple recombination events model (MREM)
Following the DMCP model (Minin 2005), MREM assumes the alignment is divided
into an unknown number of independent, non-overlapping segments separated by change
points. An unknown number M of these change points represent crossover points where
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the topology changes because of recombination. Within the same segment, sites are
independent and identically distributed.
The goal is to test for multiple recombination events by searching for polyphyly
among the recombinant sequences. If any region of the alignment supports polyphyletic
recombinants, then we conclude that at least two recombination events have occurred.
To quantitate the support for multiple events, we compute the Bayes’ factor in favor of
polyphyletic recombinants
BPM =
p(polyphyletic | D)
p(monophyletic | D) ×
q(monophyletic)
q(polyphyletic)
,
where p(· | D) is the estimated posterior probability, q(·) is the prior probability, and the
hypothesis “polyphyletic” means the recombinants are polyphyletic anywhere along the
aligned data.
The data D are N representative genotype sequences aligned with R recombinants.
Like the DMCP model, MREM, assumes a fixed genotype topology for computational
reasons, but allows the R recombinants to branch out anywhere, producing
Ttotal =
(N − 2)![2(N + R)− 5]!
(2N − 4)!2R−1(N + R− 3)!
possible topologies for N > 2 and R > 0. For R > 2 there are
Tmono =
(2N − 3)(2R− 5)!
(R− 3)!2R−3
topologies with monophyletic recombinants. Otherwise, Tmono = 2N−3. These formulae
make it clear that polyphyletic phylogenies radically dominate monophyletic phylogenies
as N or R increases.
Bayes factors can be sensitive to choice of priors (Kass 1989). To minimize the
sensitivity, the prior odds should not stray far from one (Kass 1995, Suchard 2005). In
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the original DMCP model (Minin 2005), a uniform prior on topologies leads to a high
prior probability on polyphyly and multiple events. For example, when N = 6 and
R = 2, there are Ttotal = 99 total topologies possible and Tmono = 9 are monophyletic.
When there are M = 3 crossover points, the prior probability of polyphyly is > 0.9999,
producing prior odds well above 104 À 1. To control the prior probability of polyphyly,
we modify the DMCP model prior on topologies τ = (τ1, · · · , τM+1) with the help of a
supplemental vector G = (G1, · · · , GM+1). Let Gk = 1 when the topology τk for region
k is monophyletic. Otherwise, Gk = 0. A priori, we assume segments are independently
assigned monophyly status with probability βM . To control the prior probability of
complete monophyly at level a, we set
βM = e
−
log(a)
M+1 ,
for all M = 0, 1, . . . . Given G = (G1, . . . , GM), topologies τ = (τ1, . . . , τM) are selected
uniformly from the appropriate class (polyphyletic or monophyletic) of trees with the
constraint that topologies differ across topology change points. The resulting (G, τ) can
be viewed as the realization of a Markov chain with state (Gi, τi) in region i. The initial
state distribution is uniform
p(τ1, G1) =


βM
Tmono
if G1 = 1
1−βM
Ttotal−Tmono
if G1 = 0,
over all possible monophyletic or polyphyletic trees. The transition probabilities are
p(τk, Gk|τk−1, Gk−1)
=


βM
Tmono−1
if Gk = 1, Gk−1 = 1
1−βM
Ttotal−Tmono
if Gk = 0, Gk−1 = 1
βM
Tmono
if Gk = 1, Gk−1 = 0
1−βM
Ttotal−Tmono−1
if Gk = 0, Gk−1 = 0,
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Figure 5.3 Phylogenetic profile of testing full-length recombinant sequences AY037275
and AY037277 using MREM model
which leads to the joint prior
q(τ,G | M)
=
βG1M (1− βM)1−G1
TG1mono(Ttotal − Tmono)1−G1
×
(
βM
Tmono − 1
)nMM
×
(
1− βM
Ttotal − Tmono
)nMP
×
(
βM
Tmono
)nPM
×
(
1− βM
Ttotal − Tmono − 1
)nPP
,
where counting over all k > 1,
nMM = # changepoints with Gk−1 = 1, Gk = 1
nMP = # changepoints with Gk−1 = 1, Gk = 0
nPM = # changepoints with Gk−1 = 0, Gk = 1
nPP = M − nMM − nMP − nPM .
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Figure 5.4 Phylogenetic profile of testing recombinant sequences AY037275 and
AY037277 for region 3001 to 5000 using MREM model
5.2.5 Sampling algorithm for τ
Based on the Bayes rule, the posterior distribution of the MREM model is
p(θ|D) ∝ p(D|θ)× p(θ)
∝
M+J+1−c∏
k=1

 ∏
sites i in k
p(di|τk, κk, µk)


× p(M)× p(J)× p(ξ|M)× p(ρ|J)
×
M+J+1−c∏
k=1
p(κk, µk|J)× p(Gk|M)× p(τk|M,Gk, Gk−1)
The posterior distribution with non-fixed parameter dimension can be numerically ap-
proximated using reversible jump Markov chain Monte Carlo (rjMCMC) method by ap-
plying Metropolis-Hastings (MH) algorithm within a Gibbs sampler. Each step follows
one of the moves of inserting or deleting topology change point(s), inserting or deleting
evolutionary change point(s), or updating all parameters conditional based on current
number of change points J and M . We followed the same scheme as DMCP model (Minin
et al. 2005) for most steps in rjMCMC sampler, but modified the step of adding/deleting
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topology change points. The detailed sampler that achieves mobility between spaces
with different dimensions is given in the previous paper (Minin 2005). Specifically in
order to add/delete the number of topology change points and preserve the inequality
topologies for any two adjacent regions, the DMCP model proposed to add/delete two
topology change points in one step. In our new proposal the add/delete two topology
change points is not necessary. The segment that involved in adding/deleting a break
point is not uniformly chosen from all topology segment. It is randomly chosen from
the segments that allow adding/deleting single topology change point. For example the
current state of topology parameter is (τ1, τ2, τ3, τ4, τ5) = (ABABC). To satisfied that
τm 6= τm−1 the topology change point ξ2 between the second and third topology region
is not allowed. The reason is that removing ξ2 leads the second and third regions col-
lapse into one region. It is reasonable to assign either B or A to the collapsed region
which leads the topology to be ABBC or AABC. In our proposal we uniformly choose
one of the topology change points from (ξ1, ξ3, orξ4) to be the one to delete which will
not violate the identifiability restriction. However, when two topology change points are
close to each other the probability to remove one of them is relatively small, which might
cause mixing problem. Thus, in the new proposal adding/deleting two topology change
points are implemented for the sampler to mix well.
5.2.6 Simulation study
Carr et al. (2001) report 16 HIV B/F recombinants sampled from three South Amer-
ican countries. Two of these recombinants (accessions AY037275 and AY037277) have
identical recombinant structures (Figure 5.3) and were isolated from transmission-linked
sexual partners. It is very likely that these recombinants result from the same recombi-
nation event. Analysis with our model and additional phylogenetic tests found the two
transmission-linked recombinants are monophyletic throughout the genome.
We extract a 2000 base pair region from the alignment where both recombinants
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Figure 5.5 HBV B/C recombinants. Neighbor-joining tree of 50 B/C recombinants with
the same recombinant structure. Branches supported by all 100 bootstrap
datasets are labeled. The tested branch is the one separating the accessions
in red from the accessions in black.
belong to genotype F (Figure 5.4) and use this data set to test the sensitivity of MREM.
Artificial polyphyletic data sets are generated by swapping a middle segment of one
representative F sequences with one recombinant to produce a small region of polyphyly.
The advantage of using these artificial data sets is that the region of polyphyly is known
a priori, but the properties of the sequences are otherwise authentically HIV-like. Ten
data sets with a simulated polyphyletic segment varying in length from 100 to 180 were
tested using MREM.
5.2.7 Analysis of HBV B/C recombinants
Sugauchi et al. (2002) identified 41 HBV recombinants with the same mosaic struc-
ture C-B. (Fang 2005) not only confirmed the earlier result, but identified 68 additional
recombinants with the same structure. A phylogenetic analysis of all these recombinants
identifies several clades with 100% bootstrap support. Figure 5.5 shows a pruned version
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cop1 cop2
segments log 10(bf) significance median (u-l)bci median (u-l)bci
none -0.9825 strong support monophyly
100 -0.2532 barely in favor
110 -0.2589 barely in favor
120 -0.1830 barely in favor
130 1.4363 strongly support polyphyly 35 124 17 47
140 1.3406 strongly support polyphyly 34 123 8 75
150 1.4197 strongly support polyphyly 32 124 5 47
160 1.3337 strongly support polyphyly 35 123 12 75
170 1.5795 strongly support polyphyly 35 125 13 46
180 2.5730 decisively support polyphyly 1 126 1 44
190 undefine decisively support polyphyly 0 129 5 46
Table 5.1 Simulation results: We report the length of the simulated polyphyletic seg-
ment, the log base 10 Bayes factors in favor of polyphyly, and the (Kass 1995)
interpretation of the Bayes factor significance. Columns 4 and 6 give the av-
erage posterior bias for the first and second COP, respectively. Columns 5
and 7 give the widths of the 95% Bayesian confidence intervals for the first
and second COP, respectively.
of the tree including only 50 of the total 109 B/C recombinants for clarity. We select
the longest branch with 100% bootstrap support and use MREM to test the hypoth-
esis that this branch defines two, distinct recombination events. There are too many
recombinants to include in a single analysis, so we randomly select four recombinants
(AB205120, AB073836, AB073835, AY033073), two from each group. We also select
four recombinant sequences (AB073836, 205120, AY206383, AB073841) from the larger
group as a rough control for monophyly. Both data sets were aligned to HBV genotypes
A,B,C, and D. We chose two representative sequences from each genotype as described
in the methods. The fixed parental tree relating these selected representative sequences
is shown in Figure 5.6.
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5.3 Result
5.3.1 Simulation result
We generate eleven data sets, five with a simulated polyphyletic regions of varying
length 100 to 190 and one fully monophyletic. Table 5.2.7 reports the Bayes factor in
favor of polyphyletic recombinants, as well as the bias and length of the 95% Bayesian
confidence intervals for the estimated COP locations. The significance of Bayes factors
are assessed according to the scale presented by (Kass 1995). As the length of the
polyphyletic region increases above 120, there is decisive evidence of polyphyly. The
accuracy of crossover point estimation lags behind sensitivity for polyphyly. Confidence
intervals for the COP locations did not vary much for the range of simulated data.
5.3.2 Analysis of HBV B/C recombinants
Recombinants involving genotypes B and C with a crossover point near the end of the
S gene have been observed frequently in HBV-infected individuals (Sugauchi 2002). To
determine whether these recombinants might have descended from multiple events, we
select four recombinants and six representative genotype sequences for MREM analysis.
Figure 5.7 plots a rough map of the genes along the HBV genome as well as the marginal
posterior distribution of τ and the posterior probability of polyphyly or monophyly at
each position along the genome. The plot of τ clearly indicates that all four recombinants
share the C-B recombinant structure, with a crossover point near position 500. The plot
of polyphyly vs. monophyly indicates that all four recombinants are monophyletic in the
5′ C region, but distinctly polyphyletic in the 3′ B region. The same data when analyzed
with the DMCP model are consistently 100% polyphyletic throughout the alignment,
including the 5′ region (Figure 5.8). We also test whether four recombinants selected from
the larger group (upper clade in Figure 5.5) show any evidence of polyphyly. The log10
Bayes factor BPM = −0.873, supporting monophyly. Further analysis with additional
recombinants and representative sequences may produce support for polyphyly, but we
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did not undertake an exhaustive search. We also tested tested another pair of sequences
5.3.3 Discussion
MREM tests for the possibility that multiple recombination events produced a group
of identical recombinant structures. Our simulations show that polyphyletic regions as
small as 130 nucleotides are detectable with high support for data derived from HIV-1
sequences. In general, however, sequence diversity and relationships will determine the
power to detect monophyly.
We examine six HBV B/C recombinants with identical structures and find strong
support for polyphyly. Closer analysis of the phylogeny supported in the polyphyletic
region indicates two recombinant clusters, thus at least two recombinant events. The ap-
pearance of at least two events in the history of these sequences supports the observation
that the location of the single crossover point in this recombinant is a possible recombi-
nation hotspot (Fang 2005). Assuming these are the only two recombination events in
this dataset, it is clear that the descendents of one of these events have been inordinately
successful, having been sampled 102 times in the public databases.
MREM controls the prior probability of polyphyly at any arbitrary level. Given a
uninformative prior on polyphyly, the method supports monophyly in the genotype C
region of the HBV B/C recombinants shown elsewhere to descend from multiple events.
Evidently, there is unresolved polyphyly in this region that the selected genotype C
representative sequences are unable to detect. Interestingly, the DMCP model, which
generously favors polyphyly a priori, exclusively supports polyphyly at all positions of
the alignment. It is impossible to compute a Bayes factor given this kind of result. Even
for cases where the data allow computation of a Bayes factor, DMCP results should be
treated with caution. Since the DMCP prior odds for polyphyly are often very large,
Bayes factors computed by the DMCP model are expected to be less accurate than those
computed by MREM (Kass 1995).
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Figure 5.6 HBV fixed parental tree. Neighbor-joining tree of the six selected
non-recombinant HBV genotype sequences. Bootstrap support for each
branch is included.
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Figure 5.7 MREM analysis of four HBV B/C recombinants from different subgroups.
Gene locations are plotted at the top. In the top plot, we report the combined
marginal posterior probability of all topologies assigning genotype B (solid
line), genotype C (dashed line), or other genotypes (dotted line) to the four
recombinants at each position along the genome. The bottom plot shows
the posterior support for polyphyly (gray line) or monophyly (black line) at
each genome position.
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Figure 5.8 DMCP analysis of four HBV B/C recombinants from different subgroups.
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Figure 5.9 DMCP analysis of four HBV B/C recombinants from the same majority
subgroups.
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CHAPTER 6 FUTURE DIRECTION
6.1 COP multiple recombination event model (cMREM)
The MREM model can identify multiple recombination events for recombination se-
quences with similar mosaic structures. It assigns an identical prior probability (βM) for
the recombinants being monophyletic for any topology region, which allows the user to
control the prior of recombination events easily. The MREM model has been successfully
used to identify two events from six HBV CB recombinants. However, we know that
intragenotype recombination happens probably more often than intergenotype recombi-
nation (Simmonds 2005). It is important to distinguish intra and inter- recombination
since it will affect the conclusion of single or multiple events. This is demonstrated by
an example shown in Figure 6.1.
Figure 6.1a and c represent the phylogenetic relationship generated from two data
sets. For each data set there are two representative sequences A and C and two recom-
binants q1 and q2. The horizontal lines represent the sequence alignment. There are
two recombination COPs. The solid vertical line (COP1) indicates the COP location of
intergenotype recombination, and the dash vertical line (COP2) intragenotype recombi-
nation. The topology of the corresponding segment is shown on the top of the region.
The recombination structure for Figure 6.1a is monoA−monoC− polyC, and for Figure
6.1c is monoA − polyC − monoC. Figure 6.1b and d show the possible recombination
events for q1 (solid line) and q2 (dashed line) by observing the recombination structures
in Figure 6.1a and c. Based on Figure 6.1b we can not conclude if q1 and q2 experi-
enced two recombination events at COP1. It can be either that q2 is an offspring of q1
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Figure 6.1 Recombination events affected by inter and intragenotype recombination.
a. The data has monoA − monoC − polyC structure. b Both single
and mulitple recombination events are possible for a. c The data has
monoA− polyC −monoC. d Only multiple events is possible for c
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which experienced a second intragenotype recombination at COP2, or q1 and q2 were
from independent events. However, it is clear that in Figure 6.1d q1 and q2 experienced
two recombination events at COP1, then a third intragenotype event occurred for q2 at
COP2 which led to the monophyletic region on the 3′ of the genome. The MREM model
is not able to distinguish different situation in Figure 6.1a and c and will conclude mul-
tiple recombination events for both scenario. This lead low prior of multiple events for
the MREM model. Therefore, we introduce cMREM which can identify recombination
events by handling intragenotype recombination.
6.1.1 Data for cMREM model
Suppose the aligned sequences, X, form an alignment that is divided into J + K +
M + 1 − CJ ;K+M segments. J is the number of parameter change points, across which
continuous evolutionary parameters change. K is the number of intergenotype crossover
points across which the topology changes from supporting one genotype to another. M
is the number of intragenotype crossover points, across which the topology changes, but
the genotype remains unchanged. CJ ;K+M is the number of parameter change points
that correspond with topology change points. Let τ be the vector of topologies, µ be
the vector of average branch lengths, and κ the transition/transversion ratio for each
segment. κ and µ have the same length J, while τ has length K+M. Let ξ = (ρ; χK ; χM)
be the change point locations, ρ for parameter change points, χK for intergenotype change
points and χM for intragenotype change points. We name χ = (χK ; χM) the combined
vector of topology change points.
The data Xi in the ith segment, is independent of the data in all other segments once
we condition on θ = (τ, µ, χ, ξ).
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6.1.2 The Prior
We use q(·) to represent the prior densities. The assumption
q(τ, µ, κ, ξ, J,K,M) = q(µ, κ|J)q(τ |K,M,χK , χM)q(χ,K,M) (6.1)
imposes much prior independence among parameters and separates the prior into parts
related to continuous parameters (µ, κ, ρ, J) and discrete topologies (τ, χ,K,M). The
prior on continuous parameters is unchanged from previous work (Minin,2005). Here, we
focus on the latter prior on topologies.
We start by factoring the joint prior density
q(χK ; χM ; K; M) = q(χK ; χM |K; M)q(K|K + M)q(K + M). (6.2)
The total number of topology change points K +M has a truncated Poisson distribution
q(K + M) ∝ e
−λK−λM (λK + λM)
K+M
(K + M)!
,
where λK and λM are the prior expected number of inter- and intra-genotype change
points. Because the topology change points are independently assigned inter- vs. intra-
genotype status, the Binomial distribution describes the number of intergenotype change
points conditional on the total number of topology change points
q(K|K + M) = (K + M)!
K!M !
(
λK
λK + λM
)K (
λM
λK + λM
)J
.
The topology change point locations (χK ; χM) have the distribution of the order statistics
of nearly-independent, nearly identical uniform random variables on alignment position.
Full iid status is not possible because inter- and intra-genotype change points cannot
appear at identical alignment position. By letting L be the length of the alignment, we
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find
q(λM |M) = M !(L−M − 1)!
(L− 1)! , (6.3)
and
q(χK |K,M,χM ) = K!(L−K −M − 1)!
(L−M − 1)! (6.4)
Equation 2 results because there are M! orderings of intragenotype change points, each
order having probability (L−M−1)!
(L−1)!
, since there are L−1 choices for the first change point,
L − 2 for the second, and so forth. Equation 3 results because there are K! orderings
of intergenotype change points, each with probability (L−K−M−1)!
(L−M−1)!
, since there are now
L−M − 1 choices for the first intergenotype change point, L−M − 2 for the next, and
so forth. The above two probabilities represent a factoring of q(χK ; χM |K; M).
Putting everything back together, we have
q(χK ; χM ; K; M) =
e−λK−λM (λK)
K(λM)
M(L−K −M − 1)!
(L− 1)!
For the prior on τ , we proceed to construct a non-homogeneous Markovian prior. Let
Ng be the number of genotype topologies where all Q query sequences are assigned to
genotype g. For each genotype g,Ng = Ng1+Ng0, where Ng1 are monophyletic topologies,
and Ng0 are polyphyletic topologies. Let g(τ) be a function that maps a genotype topology
to its genotype, m(τ) be function that indicates if τ is monophyletic, and c(χ) be a function
that indicates when χ is an inter-genotype change point. Finally, let ps be the prior
probability that an intergenotype change point represents a single event or undetected
multiple events. Assuming monophyly status is assigned independently to each segment,
p =
√
ps is the prior prior probability that a topology bound by an intergenotype change
point is monophyletic. With this notation, we write the joint probability using the
Markovian prior
q(τ |K; M ; χK ; χ) = q(τ1)
M+K∏
i=1
q(τi+1|τi);
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where, in moving to the right, we have dropped explicit dependence on λK ; λM for ease
of notation. We emphasize that the Markov chain is inhomogeneous precisely because
the transition probabilities do depend on λ. Also, in what follows, please note that τi is
the topology for the segment to the left of topology change point τi. If g(τ1) = g, the
initial distribution
q(τ1) =


1
GNg
c(χ1) = 0
p
GNg1
c(χ1) = 1; m(τ1) = 1
1−p
GNg0
c(χ1) = 1; m(τ1) = 0
uniformly selects genotype g and then uniformly selects an appropriate genotype g topol-
ogy. Similarly, the transition probabilities, with g(τi+1) = g, are
q(τi+1|taui) =


1
Ng−1
c(χi) = 0; c(χi+1) = 0
p
(G−1)Ng1
m(τi+1) = 1; c(χi) = 1; c(χi+1) ∈ {0, 1}
1−p
(G−1)Ng0
m(τi+1) = 0; c(χi) = 1; c(χi+1) ∈ {0, }
P
Ng1
m(τi+1) = 1; m(τ) = 0; c(χi) = 0; c(χi+1) = 1
P
Ng1−1
m(τi+1) = 1; m(τi) = 1; c(χi) = 0; c(χ + i + 1) = 1
1−p
Ng0−1
m(τi+1) = 0; m(τi) = 0; c(χi) = 0; c(χi+1) = 1
1−p
Ng0
m(τi+1) = 0; m(τi) = 1; c(χi) = 0; c(χi+1) = 1
6.1.3 The Prior Ratio
During Metropolis-Hastings Markov Chain Monte Carlo, it is necessary to compute
the ratio of the prior probability of the proposed state θ∗ over the prior probability of
the current stateθ. In some cases, this ratio takes a particularly simple form, easy to
compute. In particular, we derive the ratio for the number and locations of topology
change points. The prior ratio on τ also takes a simple form, but, from a programming
perspective, it is no more complex to compute the full prior ratio
q(τ∗|K∗;M∗;χ∗K ;χ
∗
M )
q(τ |K;M ;χK ;χM )
, so
the simplified ratio is not derived here.
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Suppose dK and dM are the proposed changes in the number of inter- and intra-
genotype change points. Then,
q(χ; K + dK; M + dM)
q(χ; K; M)
=
(λM)
dM(λK)
dK(L−M − dM −K − dK − 1)!
(L−M −K − 1)!
= (χM)
dM(χK)
dK
×


1
(L−M−K−1)···(L−M−dM−K−dK)
dK + dM > 0
(L−M − dM −K − dK − 1) · · · (L−M −K) dK + dM < 0
0 dK + dM = 0
The cMREM model has been implemented and tested on simulation data sets. It will
also be tested on real data sets for HIV/HBV recombinants sequences having identical
mosaic structures. We have identified many such recombinant HBV full-length sequences
in the previous study.
6.2 Hotspots identification for other recombinogenic viruses
The DMCP model is one of the best statistic models to study recombination. The
important feature of the DMCP model is that it estimates the accurate recombination
COP locations along the genome. In Chapter 5 we did large scale of genotyping and
recombination detection for full-length HBV sequences using DMCP model. Complicated
work is involved in testing the convergence of MCMC sampler, and point estimation of the
posterior analysis. The frame work could be applied in other potential recombinogenic
viruses such as HIV, degue virus et al.. By horizontally comparing the sequences around
the identified recombination hotspots from different viruses we might have a chance to
identify the specific DNA sequence or secondary RNA structure that are responsible for
recombination occurrence.
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6.3 Remove fixed parental tree assumption
In both DMCP model and MREM model for computational ease we assume fixed
parental tree. This assumption might be valid for the low diverse sequence data, but it
is not appropriate for analyzing high diverse data such HIV. Further detailed simulation
study on how the fixed parental tree assumption influences recombination inference is
required.
The fixed parental tree assumption can be removed for phylogenetic-based models
using different strategies. One possible way involves two steps analysis. First quickly an-
alyze data with fixed parental tree assumption to obtain the possible parental genotypes.
Then eliminates the representative sequences of the unrelated genotypes and remove the
fixed parental tree assumption to reanalyzed the data. Another possibility is to generate
the pool of possible topologies by analyzing all representative sequences. Instead of using
all possible tree just use the selected tree. This will decrease the number of possible trees.
However, allowing multiple possible trees is more likely to obtain more accurate inference
than using fixed topology. The third way to remove the fixed parental tree is implement
a fast tree building method in the model, and generate parental tree for each analyzed
segment
104
CHAPTER 7 APPENDIX: FORMULA DERIVATION OF
MCMC
7.1 Introduction
The MREM model is based on the DMCP model. The theoretical derivation for the
DMCP model has never been written up before and it is not trivial. Here I provide the
detail of the theoretical background of the MREM model. The MREM model is designed
to identify recombination event(s) by simultaneously inferring phylogenetic relationship
of multiple recombinants. In the MREM model the continuous time Markov chain,
specifically HKY85, is used for the nucleotide substitution, and rjMCMC is applied to
numerically approximate the posterior distribution with non-fixed parameter dimensions.
The data used by the MREM model is aligned DNA sequences. The model assumes
the alignment is divided into independent segments by M topology change points and J
evolutionary parameter change points. The locations of topology and evolutionary change
points are ξ = (ξ0, · · · , ξM +1) and ρ = (ρ1, · · · , ρM). All parameters in the model depend
on the number of change points M and J . Within each segment only topology parameters
τ and G are dependent, and all other parameters κ, µ are independent with each other.
Let N be the number of representative sequences for P genotypes, Q be the number of
recombinants , and S be the length of the alignment. For computational easy, the MREM
model assumes fixed parental tree, and allows the recombinant queries branching out of
any branches of the fixed parental tree. This leads u = Ttotal =
(N−2)![2(N+R)−5]!
(2N−4)!2R−1(N+R−3)!
total
possible topologies, and v = Tmono =
(2N−3)(2R−5)!
(R−3)!2R−3
possible monophyletic topologies.
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7.2 Parameters
• M : The number of topology change points.
• J : The number of evolutionary parameter change points.
• ρ: The locations of evolutionary parameter change point, ρ = (ρ1, . . . , ρJ).
• ξ: The locations of topology change point, ξ = (ξ0, ξ1, · · · , ξM , ξM+1), where ξ0, and ξM+1
are the start and the end sites of the sequence alignment.
• κ: A parameter related to the transition/transversion ratios for the regions bounded
by evolutionary parameter change points, κ = (κ0, κ1, · · · , κJ).
• µ: A parameter represents the average branch length for the regions bounded by
evolutionary parameter change points, µ = (µ0, µ1, · · · , µJ).
• (νκ, σ2κ, νµ, σ2µ): Hyper parameters for κ and µ. φ = (νκ, σ2κ, νµ, σ2µ), where νκ and
σκ are the mean and variance for κ, and νµ and σµ are the mean and variance of µ.
• G: A supplementary vector to indicate recombination event(s) for topological re-
gions. (G = G0, G1 · · · , GM). For any region i, Gi = 0 indicates polyphyletic
queries, and Gi = 1 indicates monophyletic queries.
• τ : A parameter indicates topologies for the regions separated by topological change
points, τ = (τ0, τ1, · · · , τM).
7.3 Priors
The prior of the MREM model is:
P (M,J,G, κ, µ, ρ, ξ, τ, φ) = P (G, κ, µ, ρ, ξ, τ, φ|M,J)× P (M,J)
= P (M)× P (J)× P (φ|J)× P (κ|J, φ)× P (µ|J, φ)× P (ρ|J)× P (ξ|M)× P (G, τ |M)
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7.3.1 Priors of M and J
Both M and J have truncated Poisson priors
P (M) ∝ δ
M
M !
,
P (J) ∝ λ
J
J !
.
The δ and λ are hyper parameters which are the mean of Poisson distributions for the
corresponding parameters. In MREM model δ and λ can be either assigned fixed values
based on our knowledge about the analyzed genome, or estimated. In my study fixed δ
and λ were chosen based on the data. For example by previous HBV full-length genome
recombination study we notice that most recombinant sequences have only 1 or 2 topology
change points. Therefore, we chose δ = 1 in the HBV full-length genome recombination
detection study. This leads the prior probability P (M = 1) ≈ 0.37, P (M = 2) ≈ 0.18,
and P (M = 3) ≈ 0.06. However, this prior might not be appropriate for HIV data since
it is common to observing 3 or more breakpoints for HIV recombinants. If we analyze
HIV data the δ should be adjusted with higher value, such as δ = 3 or 4.
Reasonable assumptions might be required to fix the hyper parameters. For example,
by assuming the number of evolutionary parameters (J) is related to the number of genes
(g) and the number of overlapped open reading frame (o) in the analyzed data, we let
λ = g + o.
7.3.2 Priors of κ and µ
We inherited the log Normal priors for κ and µ from the DMCP model. The log Nor-
mal distributions have hyper parameters φ = (νκ, σκ
2, νµ, σµ
2). φ can be either estimated
or fixed. When we estimate φ, if J < 4 to insure a proper posterior distribution (Gelman
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2004) we fix (νκ = 2, σκ
2 = 1) and (νµ = −2, σµ2 = 2), yielding
P (κj|νκ, σ2κ) ∝
1
κj
× e
−(log κj−2)
2
2 , and
P (µj|νµ, σ2µ) ∝
1
µj
× e
−(log µj+2)
2
8 ,
which leads to a vague and independent prior distribution on κj and µj. This leads to
the prior median of κj = 7 and κj ∈ (1, 50) with 95% probability, and the prior median
of µj is 0.1, and µj ∈ (0.003, 7) with 95% probability.
When J ≥ 4, we continue the hierarchical construction for κ and µ by assuming
diffuse, conjugate hyper priors on νκ, σκ
2 ,νµ, σµ
2.
p(νκ|J > 3) ∝ e−
ν2κ
2×1002 ,
p(νµ|J > 3) ∝ e−
ν2µ
2×1002 ,
p(σ−2κ |J > 3) ∝ σ−2(0.01−1)κ × e−
σ
−2
κ
0.01 ,
p(σ−2µ |J > 3) ∝ σ−2(0.01−1)µ × e−
σ
−2
µ
0.01 ,
Based on φ, the prior for κ and µ are:
P (κj|νκ, σ2κ) ∝
1
κj
× e
−(log κj−νκ)
2
2σ2κ , and
P (µj|νµ, σ2µ) ∝
1
µj
× e
−(log µj−µµ)
2
2σ2µ .
7.3.3 Priors of ρ and ξ
Both ρ and ξ have approximate uniform [2, S − 1] priors.
P (ξ) ∝ M !
M∏
i=1
1
S − i− 1
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P (ρ) ∝ J !
J∏
i=1
1
S − i− 1
7.3.4 Priors for G and τ
We assume an iid distribution of Gk for any M + 1 segments (k). Given a prior
probability of all queries being monophyletic for the whole alignment to be a, there is a
probability βM = P (Gk = 1) for any segment k to be monophyletic. βM is
βM = P (Gk = 1) = e
−
log(a)
M+1 ,
This prior allows to obtain a non-informative prior for multiple recombination events
easily by choosing a = 0.5.
The prior of the topology parameter τk depends on Gk.
p(τk|G,M) =


p(τ1|G1), if k = 1
p(τk|τk−1, Gk, Gk−1), if k > 1;
where
p(τ1|G1) =


1
v
if G1 is 1,
1
u−v
, if G1 is 0,
and
p(τk|τk−1, Gk, Gk−1) =


1
v−1
, if Gk = 1, Gk−1 = 1
1
u−v
, if Gk = 0, Gk−1 = 1
1
v
, if Gk = 1, Gk−1 = 0
1
u−v−1
, if Gk = 0, Gk−1 = 0,
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which leads to the joint prior of τ and G to be:
p(G, τ |M) = p(G|M)× p(τ |G,M)
= p(τ1|G1)×
M∏
k=1
p(Gk)×
M∏
k=1
p(τk|τk−1, Gk, Gk−1)
=
[
β
δG1=1
M+1 × (1− βM+1)δG1=0
(u− v)δG1=0
]
×
(
1
v − 1
)n11
×
(
1
(u− v)
)n21
×
(
1
v
)n12
×
(
1
(u− v)− 1
)M+1−n11−n12−n22
,
where δG1 =


1, if G1 = 1
0, if G1 = 0
n11 = number of regions such that Gk−1 = 1, Gk = 1, i > 1,
n12 = number of regions such that Gk−1 = 1, Gk = 0, i > 1,
n21 = number of regions such that Gk−1 = 2, Gk = 1, i > 1.
7.4 Prior ratio, proposal ratio, and likelihood ratio calculation
In each step of an rjMCMC sampler, one of the following three moves is attempted:
• updating parameters conditional on current J and M ,
• inserting / deleting topology change point(s),
• inserting / deleting evolutionary parameter change points.
The move for inserting / deleting two topology change points is implemented in the
MREM model as an option. A Metropolis-within-Gibbs sampling approach is applied
for posterior distribution sampling.
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7.4.1 Updating a new location of topology change point ξi
We update one location ξi of ξ = (ξ1, · · · , ξM) at a time. Based on the current ξi we
uniformly choose a integer w ∈ [1, l]), where l is a window size. The model assumes the
same probability for ξ∗i locating on either the left or the right side of ξi for w base pairs.
If the new ξ∗i locates on the left side of ξi−1, which means ξi − ξi−1 < w, we let the ξ∗i
bound back w− (ξi− ξi−1) base pairs. Similar situation applies for ξ∗i locates at the right
side of ξi. This will guarantee the ξ
∗
i to locate in regions i− 1 or i which are bounded by
ξi−1 and ξi+1. The prior ratio is
P (ξ∗|M)
P (ξ|M) =
P (ξ1, · · · , ξ∗i , · · · , ξM |M)
P (ξ1, · · · , ξi, · · · , ξM |M)
=
M !
∏M
i=1
1
S−i−1
M !
∏M
i=1
1
S−i−1
= 1,
The proposal ratio is
P (ξ|ξ∗)
P (ξ∗|ξ) =
P (ξ1, · · · , ξi, · · · , ξM |ξ1, · · · , ξ∗i , · · · , ξM)
P (ξ1, · · · , ξ∗i , · · · , ξM |ξ1, · · · , ξi, · · · , ξM)
=
P (ξi|ξi−1, ξ∗i , ξi+1)
P (ξ∗i |ξi−1, ξi, ξi+1)
=
1
l
1
l
= 1,
We argue that when the proposed ξ∗i reflects out of the boundary of ξi−1, the proposal
is still symmetric, and the proposal ratio is always 1. An example is used to demonstrate
in this argument. Assume w = 7, ξi − ξi−1 = 3, and the proposed ξ∗i is on the left side
of current ξi. The original ξ
∗
i is 4bp on the left of ξi−1. Let ξ
∗
i bounce back 4 bp to the
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right the new ξ∗i will be 4 bp on the right of ξi−1. The probability of the new ξ
∗
i is:
P (ξ∗i = 4bp away from ξi−1|ξi−1, ξi, ξi+1)
= P (ξi moves right 1bp) + P (ξi moves left 7bp)
= 0.5× 1
l
+ 0.5× 1
l
=
1
l
Similarly
P (ξi = 3bp away from ξi−1|ξi−1, ξ∗i , ξi+1)
= P (ξ∗i moves left 1bp) + P (ξ
∗
i moves left 7bp)
= 0.5× 1
l
+ 0.5× 1
l
=
1
l
The likelihood calculation involves parameters (κ, µ, τ). When we update ξi to ξ
∗
i κj, µj
and τm might be different between ξ
∗
i and ξi. If we assume ξi < ξ
∗
i in region [ξi, ξ
∗
i ), and
assume there are n−m + 1 evolutionary change points the region [ξi, ξ∗i ) is divided into
n−m + 2 regions. Let yj be the j th site in region [ξi, ξ∗i ). The likelihood ratio is:
likelihood ratio =
∏n
t=m+1
∏ρt+1−1
j=ρt
P (yj|κt, µt, τi)∏n
t=m+1
∏ρt+1−1
j=ρt
P (yj|κt, µt, τi+1)
×
∏ρm−1
j=ξi
P (yj|κm, µm, τi)×
∏ξ∗i −1
j=ρn
P (yj|κn+1, µn+1, τi)∏ρm−1
j=ξi
P (yj|κm, µm, τi+1)×
∏ξ∗i −1
j=ρn
P (yj|κn+1, µn+1, τi+1)
where the region m is bounded by [ξi, ρm], and the region n is bounded by [ρn, ξi].
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Similarly if ξi > ξ
∗
i :
likelihood ratio =
∏n
t=m+1
∏ρt+1−1
j=ρt
P (yj|κt, µt, τi+1)∏n
t=m+1
∏ρt+1−1
j=ρt
P (yj|κt, µt, τi)
×
∏ρm−1
j=ξ∗i
P (yj|κm, µm, τi+1)×
∏ξi−1
j=ρn
P (yj|κn+1, µn+1, τi+1)∏ρm−1
j=ξ∗i
P (yj|κm, µm, τi)×
∏ξi−1
j=ρn
P (yj|κn+1, µn+1, τi)
Updating a new evolutionary parameter change point ρi will be similar as updating
a new ξ∗i .
7.4.2 Updating evolutionary parameters κi, and µi
New κ∗i and µ
∗
i can be updated simultaneously. Let xκ ∼ normal(0, σ2κ) and xµ ∼
Normal (0, σ2µ). Then set κ
∗
i = κi + xκ µ
∗
i = µi + xµ. The prior for κ
∗
i , κi, µ
∗
i , and µi are
(when J > 3):
P (κi) =
1√
2piσκ
× e
−(log κi−νκ)
2
2σκ2 ,
P (µi) =
1√
2piσµ
× e
−(log µi−νµ)
2
2σµ2 ,
P (κ∗i ) = P (κi + xκ) =
1√
2piσκ
× e
−[log(κi+xκ)−νκ]
2
2σκ2 ,
P (µ∗i ) = P (µi + xµ) =
1√
2piσµ
× e
−[log(µi+xµ)−νµ]
2
2σµ2 ,
The prior ratio:
P (κ∗)
P (κ)
× P (µ
∗)
P (µ)
=
P (κ1, · · · , κ∗i , · · · , κJ+1)
P (κ1, · · · , κi, · · · , κJ+1) ×
P (µ1, · · · , µ∗i , · · · , µJ+1)
P (µ1, · · · , µ∗i , · · · , µJ+1)
=
P (κ∗i )
P (κi)
× P (µ
∗
i )
P (µi)
= e
(
(log κi−νκ)
2
−[log(κi+xκ)−νκ]
2
2σ2κ
+
(log µi−νµ)
2
−[log(µi+xµ)−νµ]
2
2σ2µ
)
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The proposal ratio:
P (κ|κ∗)
P (κ∗|κ) ×
P (µ|µ∗)
P (µ∗|µ)
=
P (κ1, · · · , κi, · · · , κJ+1|κ1, · · · , κ∗i , · · · , κJ+1)
P (κ1, · · · , κ∗i , · · · , κJ+1|κ1, · · · , κi, · · · , κJ+1)
×P (µ1, · · · , µi, · · · , µJ+1|µ1, · · · , µ
∗
i , · · · , µJ+1)
P (µ1, · · · , µ∗i , · · · , µJ+1|µ1, · · · , µi, · · · , µJ+1)
=
P (κi|κ∗i )
P (κ∗i |κi)
× P (µi|µ
∗
i )
P (µ∗i |µi)
= 1
The proposal ratio is 1 since both κi and µi proposers are symmetric normal.
Assume in region [ρi − 1, ρi+1) there are ξm, · · · , ξn topology change points. The
likelihood ratio is
∏ξm−1
j=ρi−1
P (yj|κ∗i , µ∗i , τm)∏ξm−1
j=ρi−1
P (yj|κi, µi, τm)
×
∏ρi−1
j=ξn
P (yj|κ∗i , µ∗i , τn+1)∏ρi−1
j=ξn
P (yj|κi, µi, τn+1)
×
∏n
t=m+1
∏ξt+1−1
j=ξt
P (κ∗i , µ
∗
i , τt)∏n
t=m+1
∏ξt+1−1
j=ξt
P (κi, µi, τt)
7.4.3 Updating Gi and τi
For MREM model the topology parameter τ depends on G. For any region i if
Gi = 1 the prior τi is uniformly chosen from v monophyletic trees, otherwise it is chosen
from u − v polyphyletic trees. Also the chosen topology has to satisfy the inequality of
the topology for any two adjacent topology segments. We can calculate the joint prior
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P (G, τ) = P (G)× P (τ |G) for i 6= 1
P (G∗, τ ∗|M)
P (G, τ |M) =
P (τ ∗|G∗,M) ∗ P (G∗|M)
P (τ |G,M) ∗ P (G|M)
=
P (G∗i |M)
P (Gi|M) ×
P (τ ∗i |τi−1, G∗i , Gi−1)
P (τi|τi−1, Gi, Gi−1) ×
P (τi+1|τ ∗i , G∗i , Gi+1)
P (τi+1|τi, Gi+1, Gi)
=


1, if G∗i = Gi
βM
1−βM
× (u−v)v
(v−1)2
, if G∗i = 1, Gi = 0, Gi−1 = 1, Gi+1 = 1,
βM
1−βM
× (u−v)−1
v−1
, if G∗i = 1, Gi = 0
1−βM
βM
× (v−1)2
(u−v)v
, if G∗i = 0, Gi = 1Gi−1 = 1, Gi+1 = 1,
1−βM
βM
× v−1
(u−v)−1
, if G∗i = 0, Gi = 1
βM
1−βM
× [(u−v)−1]2
(u−v)v
, if G∗i = 1, Gi = 0, Gi−1 = 0, Gi+1 = 0
1−βM
βM
× (u−v)v
[(u−v)−1]2
, if G∗i = 0, Gi = 1, Gi−1 = 0, Gi+1 = 0
For i = 1 the prior ratio is:
G∗1
G1
× P (τ
∗
1 )
P (τ1)
× P (τ1|τ
∗
1 , G
∗
1, G1)
P (τ1|τ1, G∗1, G1)
=


1, if G∗0 = G0
βM
1−βM
× (u−v)
(v−1)
, if G∗0 = 1, G0 = 0
1−βM
βM
× (v−1)
(u−v)
, if G∗0 = 0, G0 = 1
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The proposal ratio
proposal ratio =
P (τ,G|τ ∗, G∗)
P (τ ∗, G∗|τ,G)
=
P (G)
P (G∗)
× P (τ |G, τ
∗)
P (τ ∗|G∗, τ)
=
P (Gi)
P (G∗i )
× P (τ1, · · · , τi, · · · , τM |G1, · · · , Gi, · · · , GM , τ1, · · · , τ
∗
i , · · · , τM)
P (τ1, · · · , τ ∗i , · · · , τM |G1, · · · , G∗i , · · · , GM , τ1, · · · , τi, · · · , τM)
=
P (τi|Gi, Gi−1, Gi+1, τi−1, τ ∗i , τi+1)
P (τ ∗i |G∗i , Gi−1, Gi+1, τi−1, τi, τi+1)
=


1, if G∗i = Gi
v−1
(u−v)
, if G∗i = 1, Gi = 0, Gi−1 = 1, Gi+1 = 1, τi−1 = τi+1
2N−5
(u−v)
, if G∗i = 1, Gi = 0, Gi−1 = 1, Gi+1 = 1, τi−1 6= τi+1
v−1
(u−v)−1
, if G∗i = 1, Gi = 0
(u−v)
v−1
, if G∗i = 0, Gi = 1, Gi−1 = 1, Gi+1 = 1, τi−1 = τi+1
(u−v)
2N−5
, if G∗i = 0, Gi = 1Gi−1 = 1, Gi+1 = 1, τi−1 6= τi+1
(u−v)−1
v−1
, if G∗i = 0Gi = 1
v
(u−v)−1
, if G∗i = 1, Gi = 0, Gi−1 = 0, Gi+1 = 0, τi−1 = τi+1
v
(u−v)−2
, if G∗i = 1, Gi = 0, Gi−1 = 0, Gi+1 = 0, τi−1 6= τi+1
(u−v)−1
v
, if G∗i = 0, Gi = 1, Gi−1 = 0, Gi+1 = 0, τi−1 = τi+1
(u−v)−2
v
, if G∗i = 0, Gi = 1, Gi−1 = 0, Gi+1 = 0, τi−1 6= τi+1
Assume in region [ξi−1, ξi) there are ρm, · · · , ρn change points. The likelihood ratio:
∏ρm−1
j=ξi−1
P (yj|κm, µm, τ ∗i )∏ρm−1
j=ξi−1
P (yj|κm, µm, τi)
×
∏ξi−1
j=ρn
P (yj|κn+1, µ∗n+1, τ ∗i )∏ξi−1
j=ρn
P (yj|κn+1, µn+1, τi)
×
∏n
t=m+1
∏ρt+1−1
j=ρt
P (κt, µt, τ
∗
i )∏n
t=m+1
∏ρt+1−1
j=ρt
P (κt, µt, τi)
7.4.4 Adding one evolutionary parameter change point
Let c be the number of topology and evolutionary parameter change points having
the same location on the genome. By adding a evolutionary parameter the parameter
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dimension is changed from l = 3(M +J +1)−c to a new state l∗ = 3[M +(J +1)+1]−c.
To calculate the transition probability of this change a dummy parameter e with length
l∗− l = 3 is introduced. A bijection function f must be defined such that f(θM+J−c, e) =
θM+(J+1)−c. Let bJ be the probability of adding an arbitrary evolutionary parameter
change point ρ∗i , and dJ be the probability of delete ρ
∗
i .
P(birth a evolutionary change point ρ∗i | current parameters)
= P (θM+(J+1)−c, birth | θM+J−c)
= P (θM+(J+1)−c | birth, θM+J−c)× P (birth | θM+J−c)
= P (θM+(J+1)−c | birth, θM+J−c)× bJ
= P (f(θM+J−c, e | birth, θM+J−c)× bJ
= P (θM+J−c, e | birth, θM+J−c)× |J | × bJ
= P (θM+J−c | birth, θM+J−c)× P (e | birth, θM+J−c)× |J | × bJ
= P (e | birth, θM+J−c)×
∣∣∣∣ ∂(θM+J−c,e)∂f(θM+J−c,e)
∣∣∣∣× bJ
Let e = (Zρ, Zκ, Zµ). Assume a new evolutionary change point ρ
∗
i lands in segment i
which is bounded by ρi−1 and ρi. After adding the new ρ
∗
i the previous segment i is
divided into two segments i∗ and (i + 1)∗. The parameters in segment i are changed
from (κi, µi) to (ρ
∗
i , κ
∗
i , κ
∗
i+1, µ
∗
i , µ
∗
i+1), and the parameters in all other segments will be
the same. The bijection function is
f(θM+J−c, e) = f(e, κi, µi) = f(Zρ, Zκ, Zµ, κi, µi) =


ρ∗i
κ∗i
κ∗i+1
µ∗i
µ∗i+1


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Let Zρ, Zκ, Zµ be r.v. with
Zρ ∼ Unif [1, S − ρ1, ρ1, · · · , ρJ , ρJ+1],
Zκ ∼ N(0, 1),
Zµ ∼ N(0, 1)
Let wl = ρ
∗
i − ρi−1 be the length of the segment between [ρi−1, ρ∗i ), and wr = ρ∗i+1 − ρ∗i
be the length of the segment [ρ∗i , ρ
∗
i+1). The bijection function f is
f1(Zρ, Zκ, Zµ, κi, µi) = ρ
∗
i =
1
S − J − 2
f2(Zρ, Zκ, Zµ, κi, µi) = κ
∗
i = κi × ewrσ
2
κZκ
f3(Zρ, Zκ, Zµ, κi, µi) = κ
∗
i+1 = κi × e−wlσ
2
κZκ
f4(Zρ, Zκ, Zµ, κi, µi) = µ
∗
i = µi × ewrσ
2
µZµ
f5(Zρ, Zκ, Zµ, κi, µi) = µ
∗
i+1 = µi × e−wlσ
2
µZµ
The Jacobian determinant is:
∣∣∣∣ 1J
∣∣∣∣ =
∣∣∣∣∣∣∣∣∣∣
∂f1
∂Zρ
∂f1
∂Zκ
∂f1
∂Zµ
∂f1
∂κi
∂f1
∂µi
...
...
...
...
...
∂f5
∂Zρ
∂f5
∂Zκ
∂f5
∂Zµ
∂f5
∂κi
∂f5
∂µi
∣∣∣∣∣∣∣∣∣∣
=
∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣
1 0 0 0 0
0 κiwrσ
2
κe
wrσ
2
κZκ 0 ewrσ
2
κZκ 0
0 −κiwrσ2κe−wlσ2κZκ 0 e−wlσ2κZκ 0
0 0 µiwrσ
2
µe
wrσ
2
µZµ 0 ewrσ
2
µZµ
0 0 −µiwlσ2µewrσ2µZµ 0 e−wlσ2µZµ
∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣
= 4κiµiwrwlσ
2
κσ
2
µe
(wr−wl)(σ
2
κZκ+σ
2
µZµ)
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and
P (e | birth, θM+J−c)× bJ = P (Zρ, Zκ, Zµ | birth, θM+J−c)× bJ
= P (Zρ | birth, θM+J−c)× P (Zκ | birth, θM+J−c)× P (Zµ | birth, θM+J−c)× bJ
=
1
S − J − 2 ×
1
2pi
× e−(Z2κ+Z2µ) × bJ
The proposal of death is simpler. We need to obtain κi, µi given κ
∗
i , κ
∗
i+1, µ
∗
i , µ
∗
i+1. When
κ∗i , κ
∗
i+1, µ
∗
i , µ
∗
i+1 are determined, Zκ, Zµ are determined, and κi, µi is determined.
P (θM+J−c | death, θM+J+1−c) = 1
P (Delete the change point ρ∗i | current parameters) = dj/(J + 1)
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. The prior ratio is:
prior ratio =
P (θM+(J+1)−c)
P (θM+J−c)
=
P (M,J + 1, ξ, G, τ, ρ∗, κ∗, µ∗)
P (M,J, ξ,G, τ, ρ, κ, µ)
=
P (M)× P (ξ|M)× P (G|M)× P (τ |M,G)× P (J + 1)
P (M)× P (ξ|M)× P (G|M)× P (τ |M,G)× P (J)
×P (ρ
∗|J + 1)× P (κ∗|J + 1)× P (µ∗|J + 1)
P (ρ|J)× P (κ|J)× P (µ|J)
=
P (J + 1)
P (J)
× P (ρ1, · · · , ρ
∗
i , ρ
∗
i+1 · · · , ρ∗J+1|J + 1)
P (ρ1, · · · , ρi, ρi+1, · · · , ρJ |J)
×P (κ0, · · · , κi−1, κ
∗
i , κ
∗
i+1, · · · , κ∗J+1|J + 1)
P (κ0, · · · , κi−1, κi, · · · , κJ |J)
×P (µ0, · · · , µi−1, µ
∗
i , µ
∗
i+1, · · · , µ∗J+1|J + 1)
P (µ0, · · · , µi−1, µi, · · · , µJ |J) ,
=
λJ+1e−λ/(J + 1)!
λJe−λ/J !
× (
∏J
i=1
1
S−i−1
)× 1
S−J−2∏J
i=1
1
S−i−1
×P (κ
∗
i = κie
wrσ
2
κZκ |J + 1)× P (κ∗i+1 = κie−wlσ2κZκ |J + 1)
P (κi|J)
×P (µ
∗
i = µie
wrσ
2
µZµ |J + 1)× P (µ∗i+1 = µie−wlσ2µZµ |J + 1)
P (µi|J)
=
λ
(J + 1)(S − J − 2)× 2piσκσµ
×e
−(log(κie
wrσ
2
κZκ )−νκ)
2
−(log(κie
−wlσ
2
κZκ )−νκ)
2+(logκi−νκ)
2
2σ2κ
×e
−(log(µie
wrσ
2
µZµ )−νµ)
2
−(log(µie
−wlσ
2
µZµ )−νµ)
2+(logµi−νµ)
2
2σ2µ
The proposal ratio is
proposal ratio =
(Delete the Change Point ρ∗i |θM+(J+1)−c)
P (Add the Change Point ρ∗i |θM+J−c)
=
dJ
P (e|birth, θM+J−c)× bJ × (J + 1) ×
∣∣∣∣ ∂(θM+J−c,e)∂(θM+(J+1)−c)
∣∣∣∣
=
dJ
P (e|birth, θM+J−c)× bJ × (J + 1) ×
∣∣∣∣ ∂(θM+J−c,e)∂f(θM+J−c,e)
∣∣∣∣
=
dJ
1
S−J−2
× 1
2pi
× e−(Z2κ+Z2µ) × bJ × (J + 1)
× 4κiµiwrwlσ2κσ2µe(wr−wl)(σ
2
κZκ+σ
2
µZµ)
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After adding ρ∗i the combination of evolutionary and topology parameters for certain
region between [ρi−1, ρi) might be changed. Assume after adding ρ
∗
i the region [ρi−1, ρ
∗
i )
takes the evolutionary parameter values of the original i region. Also assume in region
[ρ∗i , ρi+1) there are t topology change points. It is very likely that the combination of
(κj, µj, and τm) in (i+1)
∗ region will be different from region i∗. Also region (i+1)∗ will
be the only region having different likelihood before and after adding ρ∗i . The likelihood
ratio for the whole alignment is
likelihood ratio =
∏n+1
t=m L(κ
∗
i , µ
∗
i , τt|yt)∏n+1
t=m L(κi, µi, τm, τt|yt)
=
∏n−1
t=m
∏ξt+1−1
j=ξt
P (yj|κ∗i , µ∗i , τt)∏n−1
t=m
∏ξt+1−1
j=ξt
P (yj|κi, µi, τt)
×
∏ξm−1
j=ρ∗i
P (yj|κ∗i , µ∗i , τm)×
∏ρi−1
j=ξn
P (yj|κ∗i+1, µ∗i+1, τn+1)∏ξm−1
j=ρ∗i
P (yj|κi, µi, τm)×
∏ρi−1
j=ξn
P (yj|κi, µi, τn+1)
7.5 Add one topology change point
Different topologies are required on both sides of a topology change point. Assume a
ξ∗i is added in region i which is bounded by [ξi−1, ξi). ξ
∗
i divided region i into i
∗ and (i+1)∗
regions. We randomly choose one region from i∗ and (i+1)∗ regions to inherit (Gi, ξi). If
τ ∗i = τi, then τ
∗
i+1 6= τi and τ ∗i+1 6= τi+1. Otherwise τ ∗i+1 = τi, then τ ∗i 6= τi and τ ∗i 6= τi−11.
To calculate the transition probability of changing from current state with parameter
dimension with length l = 3(M + J + 1) − c to a new state with parameter dimension
with length l∗ = 3[(M+1)+J+1]−c parameters a dummy vector e with length l∗−l = 3 is
introduced. A bijection function f has to be defined such that f(θM+J−c, e) = θ(M+1)+J−c.
Let bM be the probability of adding a ξ
∗
i , and dM be the probability of deleting the ξ
∗
i .
Let e = (Zξ, ZG, Zτ ), and all (ξ,G, τ) are discrete random variable. After adding ξ
∗
i , the
parameters in region i change from (Gi, τi) to (ξ
∗
i , G
∗
i , G
∗
i+1, τ
∗
i , τ
∗
i+1). Given the bijection
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function f we have
f(θM+J−c, u) = f(Zξ, ZG, Zτ , Gi, τi) =


ξ∗i
G∗i
G∗i+1
ξ∗i
ξ∗i+1


Let Zξ, ZG, Zτ be r.v. with
Zξ ∼ Unif [1, S ξ0, ξ1, · · · , ξM , ξM+1],
ZG ∼ Unif [1, 2],
Zτ ∼ Unif [possible topologies given ZG, the G and τ in the previous region]
The bijection function for τ ∗i = τi
f1(Zξ, ZG, Zτ , Gi, τi) = ξ
∗
i =
1
S − J − 2 ,
f2(Zξ, ZG, Zτ , Gi, τi) = G
∗
i = Gi = 1,
f3(Zξ, ZG, Zτ , Gi, τi) = G
∗
i+1 = 0.5,
f4(Zξ, ZG, Zτ , Gi, τi) = τ
∗
i = τi = 1,
f5(Zξ, ZG, Zτ , Gi, τi) = τ
∗
i+1,
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and
P (τ ∗i+1|ZG, τi, Gi, ZG, Gi+1, τi+1) =


1
2N−5
, if Gi = ZG = Gi+1 = 1
1
(u−v)2
, if Gi = ZG = Gi+1 = 0
1
v−1
, if Gi = ZG = 1, Gi+1 = 0
1
(u−v)−1
, if Gi = ZG = 0, Gi+1 = 1
1
(u−v)
, if Gi = 1, ZG = Gi+1 = 0
1
v
, if Gi = 0, ZG = Gi+1 = 1
The bijection function for τ ∗i+1 = τi
f1(Zξ, ZG, Zτ , Gi, τi) = ξ
∗
i =
1
S − J − 2 ,
f2(Zξ, ZG, Zτ , Gi, τi) = G
∗
i = 0.5,
f3(Zξ, ZG, Zτ , Gi, τi) = G
∗
i+1 = Gi = 1,
f4(Zξ, ZG, Zτ , Gi, τi) = τ
∗
i ,
f5(Zξ, ZG, Zτ , Gi, τi) = τ
∗
i+1 = τi = 1,
P (τ ∗i |ZG, τi−1, Gi−1, ZG, Gi, τi) =


1
2N−5
, if Gi−1 = ZG = Gi = 1
1
(u−v)−2
, if Gi−1 = ZG = Gi = 0
1
v−1
, if Gi−1 = ZG = 1, Gi = 0
1
(u−v)−1
, if Gi−1 = ZG = 0, Gi = 1
1
(u−v)
, if Gi−1 = 1, ZG = Gi = 0
1
v
, if Gi−1 = 0, ZG = Gi = 1
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and
P (Add one topology change point|θM+J−c) = P (θ(M+1)+J−c|birth, θM+J−c)× P (birth|θM+J−c)
= P (f(θM+J−c, e))× bM
= P (e|birth, θM+J−c)× bM
= P (Zξ, ZG, Zτ )|birth, θM+J−c × bM
= P (Zξ|birth, θM+J−c)× P (ZG|birth, θM+J−c)× P (Zτ |ZG, birth, θM+J−c)× bM
=
bM
2(S − J − 2) ×


P (Zτ |ZG, τi, Gi, ZG, Gi+1, τi+1), if τ ∗i = τi
P (Zτ |ZG, τi−1, Gi−1, ZG, Gi, τi), if τ ∗i+1 = τi
which P (Zτ |ZG, τi, Gi, ZG, Gi+1, τi+1), and P (Zτ |ZG, τi−1, Gi−1, ZG, Gi, τi) have been cal-
culated.
P (Delete the topology point ξ∗i ) = dM/(M + 1)
The prior for P (ξ∗|M +1) and P (ξ|M) are ordered statistics. The prior for ξ is P (ξ∗|M +
1) = (M + 1)! ∗∏M+1i=1 1S−i . Hence, the prior ratio for ξ is M+1S−i−1 .
P (θ(M+1)+J−c)
P (θM+J−c)
=
P (J)× P (ρ|J)× P (κ|J)× P (µ|J)
P (J)× P (ρ|J)× P (κ|J)× P (µ|J)
×P (M + 1)× P (ξ
∗|M + 1)× P (G∗|M + 1)× P (τ ∗|G∗,M + 1)
P (M)× P (ξ|M)× P (G|M)× P (τ |G,M)
=
P (M + 1)× P (G0, · · · , Gi−1, G∗i , G∗i+1, G∗i+2, · · · , G∗M+1)
P (M)× P (G0, · · · , Gi−1, Gi, Gi+1, · · · , GM)
×P (τ0, · · · , τi−1, τ
∗
i , τ
∗
i+1, τ
∗
i+2, · · · , τ ∗M+1|G,M + 1)
P (τ0, · · · , τi−1, τi, τi+1, · · · , τM |G,M)
×P (ξ1, · · · , ξi−1, ξ
∗
i , ξ
∗
i+1, ξi+1, · · · , ξM |M + 1)
P (ξ1, · · · , ξi−1, ξi, ξi+1, · · · , ξM |M)
=
δ
(S −M − 1)
×


P (G∗i+1)× P (τ ∗i |G∗i , τi−1, Gi−1)× P (τi+1|τ ∗i+1, ZG, Gi+1), if τ ∗i = τi
P (G∗i )× P (τ ∗i |ZG, τi−1, Gi−1)× P (τi|ZG, Gi, τ ∗i ), if τ ∗i+1 = τi
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When τ ∗i = τi prior ratio is
δ × P (G∗i+1)× P (τ ∗i |τi−1, Gi−1, G∗i )× P (τi+1|τ ∗i+1, ZG, Gi+1)
δ ×


βM
v−1
, if Gi = ZG or ZG = Gi+1 = 1
1−βM
(u−v)−1
, if Gi = ZG = 2ZG = Gi+1 = 0
(1−βM )(v−1)
(u−v)v
, if Gi = Gi+1 = 1, ZG = 0
βM [(u−v)−1]
(u−v)v
, if Gi = Gi+1 = 0, ZG = 1
When τ ∗i+1 = τi prior ratio is
δ × P (G∗i+1)× P (τ ∗i |ZGτi−1, Gi−1)× P (τi+1|τ ∗i+1, ZG, Gi+1)
δ ×


βM
v−1
, if Gi−1 = ZG or ZG = Gi = 1
1−βM
(u−v)−1
, if Gi−1 = ZG = 2ZG = Gi = 0
(1−βM )(v−1)
(u−v)v
, if Gi−1 = Gi = 1, ZG = 0
βM [(u−v)−1]
(u−v)v
, if Gi−1 = Gi = 0, ZG = 1
Proposal ratio is
P (θM+J−c|θ(M+1)+J−c)
P (θ(M+1)+J−c|θM+J−c)
dM × 2(S −M − 2)
bm × P (Zτ |birth, ZG, θM+M−c)
dM × 2(S −M − 2)
bm
×


1
P (τ∗i |ZGτi−1,Gi−1,τi,Gi)
, if τ ∗i = τi
1
P (τ∗i |ZG,τi−1,Gi−1,τi,Gi)
, if τ ∗i+1 = τi
Assume there are n −m + 1 evolutionary parameter change points in region [ξ∗i , ξi]. If
τ ∗i = τi the likelihood ratio is
∏n−1
t=m
∏ρt+1−1
j=ρt
P (yj|κt+1, µt+1, τ ∗i+1)∏n−1
t=m
∏ρt+1−1
j=ρt
P (yj|κt+1, µt+1, τi)
×
∏ρm−1
j=ξ∗i
P (yj|κm, µm, τ ∗i+1)∏ρm−1
j=ξ∗i
P (yj|κm, µm, τi)
×
∏ξi−1
j=ρn
P (yj|κn+1, µn+1, τ ∗i+1)∏ξi−1
j=ρn
P (yj|κn+1, µn+1, τi)
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Otherwise τ ∗i+1 = τi the likelihood ratio is
∏n−1
t=m
∏ρt+1−1
j=ρt
P (yj|κt+1, µt+1, τ ∗i+1)∏n−1
t=m
∏ρt+1−1
j=ρt
P (yj|κt+1, µt+1, τi)
×
∏ρm−1
j=ξi−1
P (yj|κm, µm, τ ∗i )∏ρm−1
j=ξi−1
P (yj|κm, µm, τi)
×
∏ξ∗i −1
j=ρn
P (yj|κn+1, µn+1, τ ∗i )∏ξ∗i −1
j=ρn
P (yj|κn+1, µn+1, τi)
7.5.1 logRatio calculation
The MREM model uses the same proposal as the DMCP model for adding one topol-
ogy change point. The logRatio calculation is the same except the prior ratio which
involves the new parameter G. There are three different cases for adding one topology
change point.
• case 1: There is only one topology region with ξ = (ξ0 = 0, ξ1 = S). After add a
new topology change point ξ∗1 we get ξ = (ξ0, ξ
∗
1 , ξ1).
• case 2: There are two topology regions with ξ = (ξ0, ξ1, ξ2). When the new added
topology change point locates in the first topology region we have ξ = (ξ0, ξ
∗
1 , ξ1, ξ2),
and when it locates in the 2nd topology region we will have ξ = (ξ0, ξ1, ξ
∗
2 , ξ2).
• case 3: The alignment has three or more topology change regions. By adding a
new ξ∗i we have ξ = (ξ0, · · · , ξi−1, ξ∗i , ξi, ξi+1, · · · , ξM+1).
First we focus on detail of calculating the prior ratio of the parameter G and the topology
parameter τ . The prior ratio of G follows a general rule for all three cases:
P (G∗|M + 1)
P (G|M) =
P (G∗1) · · ·P (G∗i−1)
P (G1) · · ·P (Gi−1) ×
P (G∗i )P (G
∗
i+1)
′
P (Gi)
=
M∏
j=1
P (G∗j)
P (Gj)
× P (Gnew proposed)
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Let the first term in the above equation be gRatio. The prior ratio is
P (τ ∗|G∗,M + 1)
P (τ |G,M) =
P (τ1|G1) · · ·P (τi−1|Gi−1)
P (τ1|G1) · · ·P (τi−1|τi−2, Gi−2, Gi−1)
×P (τ
∗
i |τi−1, Gi−1, G∗i )× P (τ ∗i+1|τ ∗i , G∗i , G∗i+1)× P (τi+1|τ ∗i+1, G∗i+1, Gi+1)
P (τi|τi−1, Gi−1, Gi)× P (τi+1|τi, Gi, Gi+1)
×P (τi+2|τi+1, Gi+1, Gi+2) · · ·P (τM |τM−1, GM−1, GM)
P (τi+2|τi+1, Gi+1, Gi+2) · · ·P (τM |τM−1, GM−1, GM)
7.5.2 case 1
The prior ratio for topology and G is:
P (τ ∗1 |G∗1)× P (τ ∗2 |τ ∗1 , G∗1, G∗2)
τ1|G1 ×
P (G∗|M + 1)
P (G|M)
=


P (τ ∗2 |τ1, G1, G∗2)× P (G
∗|M+1)
P (G|M)
,if τ ∗1 = τ1
P (τ∗1 |G
∗
1)×P (τ1|τ
∗
1 ,G
∗
1,G1)
P (τ1|G1)
× P (G∗|M+1)
P (G|M)
,if τ ∗2 = τ1
When τ ∗1 = τ1 the prior ratio is:


gRatio× β∗
v−1
, if G1 = 1, G
∗
2 = 1
gRatio× 1−β∗
(u−v)
, if G1 = 1, G
∗
2 = 0
gRatio× β∗
v
, if G1 = 0, G
∗
2 = 1
gRatio× 1−β∗
(u−v)−1
, if G1 = 0, G
∗
2 = 0
When τ ∗2 = τ1, the prior ratio is:


gRatio× β∗
v−1
, if G∗1 = G1 = 1
gRatio× 1−β∗
(u−v)
, if G∗1 = G1 = 0
gRatio× β∗
v
, if G∗1 = 1, G1 = 0
gRatio× 1−β∗
(u−v)
, if G∗1 = 0, G1 = 1
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7.5.3 case 2
The prior ratio for topology and G is:


P (τ∗2 |τ1,G1,G
∗
2)×P (τ
∗
3 |τ
∗
2 ,G
∗
2,G
∗
3)
P (τ2|τ1,G1,G2)
× P (G∗|M+1)
P (G|M)
, if add ξ∗2
P (τ∗1 |G
∗
1)×P (τ
∗
2 |τ
∗
1 ,G
∗
1,G
∗
2)×P (τ2|τ
∗
2 ,G
∗
2,G2)
P (τ1|G1)×P (τ2|τ1,G1,G2)
, if add ξ∗1
For add ξ∗2 , we let τ
∗
2 = τ2 and τ
∗
3 = τ2 with the same probability. The prior ratio are:


P (τ ∗3 |τ ∗2 , G∗2, G∗3), if τ ∗2 = τ2
P (τ∗2 |τ1,G1,G
∗
2)×P (τ2|tau
∗
2,G
∗
2,G2)
P (τ2|τ1,G1,G2)
, if τ ∗3 = τ2
When τ ∗2 = τ2 the prior ratio as:
P (τ ∗3 |τ ∗2 , G∗2, G∗3) =


gRatio× β∗
v−1
, if G∗2 = G
∗
3 = 1
gRatio× 1−β∗
(u−v)−1
, if G∗2 = G
∗
3 = 0
gRatio× β∗
v
, if G∗2 = 0G
∗
3 = 1
gRatio× 1−β∗
(u−v)
, if G∗2 = 1G
∗
3 = 0
When τ ∗3 = τ2 we have prior ratios as:
P (τ ∗2 |τ1, G1, G∗2)× P (τ2|tau∗2, G∗2, G2)
P (τ2|τ1, G1, G2)
=


gRatio× β∗
v−1
, if G1 = G2
∗ = 1, orG∗2 = G2 = 1
gRatio× 1−β∗
(u−v)−1
, if G1 = G2
∗ = 0, or G∗2 = G2 = 0
gRatio× (1−β∗)(v−1)
(u−v)v
, if G1 = G2 = 1, G
∗
2 = 0
gRatio× β∗[(u−v)−1]
(u−v)v
, if G1 = G2 = 0, G
∗
2 = 1
If we add ξ∗1 , the formula’s τ
∗
1 = τ1 and τ
∗
2 = τ1 are:


P (τ∗2 |τ
∗
1 ,G
∗
1,G
∗
2)×P (τ2|τ
∗
2 ,G
∗
2,G2)
P (τ2|τ1,G1,G2)
× P (G∗|M+1)
P (G|M)
, if τ ∗1 = τ1
P (τ∗1 |G
∗
1)×P (τ2|τ1,G1,G2)
P (τ1|G1)
× P (G∗|M+1)
P (G|M)
, if τ ∗2 = τ1
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When τ ∗1 = τ1, it is exactly the same as when τ
∗
3 = τ2 for adding ξ
∗
2 . When τ
∗
2 = τ1, the
prior ratios are:
P (τ ∗1 |G∗1)× P (τ2|τ1, G1, G2)
P (τ1|G1) × fracP (G
∗|M + 1)P (G|M)
=


gRatio× β∗
v−1
, if G∗1 = G1 = 1
gRatio× 1−β∗
(u−v)−1
, if G∗1 = G1 = 0
gRatio× 1−β∗
(u−v)
, if G∗1 = 0, G1 = 1
gRatio× β∗
v
, if G∗1 = 1, G1 = 0
7.5.4 case 3
The prior ratio for G and τ is:
P (G∗|M + 1)× P (τ ∗|G∗,M + 1
P (G|M)× P (τ |M)
=


gRatio× P (G∗i+1)× P (τ
∗
i+1|τi,Gi,G
∗
i+1)P (τi+1|τ
∗
i+1,G
∗
i+1,Gi+1)
P (τi+1|τi,Gi,Gi+1)
, if τ ∗i = τi
gRatio× P (G∗i )× P (τ
∗
i |τi−1,Gi−1,G
∗
i )P (τi|τ
∗
i ,G
∗
i ,Gi)
P (τi|τi−1,Gi−1,Gi)
, if τ ∗i+1 = τi
When τ ∗i = τi, the prior ratio is the same as when τ
∗
3 = τ2 for adding ξ
∗
2 , where G1, G
∗
2
and G2 are Gi, G
∗
i+1, and Gi+1. When τ
∗
i+1 = τi, the prior ratio is the same as when
τ ∗3 = τ2 for adding ξ
∗
2 , where G1, G
∗
2 and G2 are τi−1, τ
∗
i , and τi.
The proposal ratio calculation is easy. In general we uniformly choose a tree from all
possible topologies. Given the chosen tree the probability of G is always 1. So proposal
ratio doesn’t involve G calculation. When the added segment is not in the 1st or the
last segment, the probability of chosen a tree different from its adjacent segments is
proposalRatio = 1
2N−5
. Otherwise it is proposalRatio = 1
v−1
. The logRatio is
αθK , θK+1
αθK+1,θK
= log(likelihoodRatio) + log(topdk1)− log(topbk1)
−2× log(M + 1) + log(priorRatio)− log(proposalRatio) + log(δ)
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GLOSSARY
• Bayesian inference: Bayesian probability theory describes the world or the interest
by combining common-sense knowledge and the observational evidence into formu-
lation of a uncertain model.
• Conjugate prior: In Bayesian probability theory, a conjugate prior is a family of
prior probability distributions which has the property that the posterior probability
distribution also belongs to that family.
• DNA: Deoxyribonucleic acid (DNA) is a nucleic acid that contains the genetic
instructions specifying the biological development of all cellular forms of life (and
many viruses)
• Gene: Genes are regions of nucleic acid that parents pass to offspring during
reproduction as chromosomes in nuclei of gametes. These entities encode informa-
tion essential for the construction and regulation of proteins (such as enzymes) and
other molecules that determine the growth and functioning of the organism.
• Gene duplication: Gene duplication occurs when an error in DNA replication leads
to the duplication of a region of DNA containing a (generally functional) gene.
• Genetic mutation: Mutations are permanent, sometimes transmissible (if the change
is to a germ cell) changes to the genetic material (usually DNA or RNA) of a cell
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• Genetic reassortment: Reassortment, occurs only in multipartite viruses and in-
volves swapping one or more of the discrete RNA molecules that makes up the
segmented viral genome.
• Genetic recombination: Genetic recombination shuﬄes genes between homologous
or non-homologous species and generates novel offspring which is a combinations
of the parental genomes.
• Genome: The DNA code that comprises the complete genetic composition of an
organism.
• Gibbs-sampling: Gibbs sampling is an algorithm to generate a sequence of sam-
ples from the joint probability distribution of two or more random variables. The
purpose of such a sequence is to approximate the joint distribution (as with a
histogram), or to compute an integral (such as an expected value).
• Informative site: A terminology of the aligned data used for phylogenetic analysis.
An informative site requires the same sequence character appears for at least two
taxa.
• DNA Insertion/deletion: The addition/deletion of DNA into a genetic sequence.
• Markov chain: A Markov chain is a discrete-time stochastic process with the
Markov property. In such a process, the past is irrelevant for predicting the fu-
ture given knowledge of the present.
• Markov chain Monte Carlo (MCMC): MCMC algorithm are a class of algorithms
for sampling from probability distributions based on constructing a Markov chain
that has the desired distribution as its stationary distribution.
• Markov property: A stochastic process has the Markov property if the conditional
probability distribution of future states of the process, given the present state,
depends only upon the current state.
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• MH algorithm: the Metropolis-Hastings algorithm is an algorithm used to generate
a sequence of samples from the probability distribution of one or more variables.
The purpose of such a sequence is to approximate the distribution (as with a his-
togram), or to compute an integral (such as an expected value).
• Molecular phylogeny: Molecular phylogeny is the use of a gene’s molecular char-
acteristics to classify an organism and to place it on a map of evolutionary rela-
tionships known as the phylogenetic tree.
• Monte Carlo method: Monte Carlo methods are a class of computational algorithms
for simulating the behavior of various physical and mathematical systems. They
are distinguished from other simulation methods (such as molecular dynamics) by
being stochastic, that is nondeterministic in some manner - usually by using random
numbers (or more often pseudo-random numbers) - as opposed to deterministic
algorithms.
• Phylogenetic tree: A phylogenetic tree is a tree showing the evolutionary inter-
relationships among various species or other entities that are believed to have a
common ancestor. A phylogenetic tree is a form of a cladogram. In a phylogenetic
tree, each node with descendants represents the most recent common ancestor of
the descendants, and edge lengths correspond to time estimates.
• Posterior distribution: In Bayesian probability theory, a posterior distribution is
the conditional probability distribution of the uncertain quantity given the data. It
can be calculated by multiplying the prior probability distribution by the likelihood
function, and then dividing by the normalizing constant.
• Prior distribution: In Bayesian probability theory, a prior distribution is the prob-
ability distribution that would express one’s uncertainty about quantity p before
the ”data” are taken into account. It is meant to attribute uncertainty rather than
randomness to the uncertain quantity.
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• purine: The general term purine refers to substituted purine and their tautomers.
Two of the bases in nucleic acids, adenine (A) and guanine (G), are purines. In
DNA, these bases form hydrogen bonds with their complementary pyrimidines
thymine (T ) and cytosine (C).
• Pyrimidine: Three nucleobases found in nucleic acids, namely cytosine (C), thymine
(T ), and uracil (U), are pyrimidine derivatives. In DNA and RNA, these bases form
hydrogen bonds with their complementary purines.
• Recombination cross-over point: The location on a genome where recombination
event occurs.
• Stationary distribution: For a posterior distribution of a Markov chain if there
exists one or more state such that
pi(X) =
∫
P (X|Y )pi(Y )dY
Then the distribution is called a stationary distribution. If the Markov chain is
positive recurrent, there exists a stationary distribution. If it is positive recurrent
and irreducible, there exists a unique stationary distribution.
• Virus genotypes: Based on genetic diversity the highly variable viruses can be
defined into different groups based on geographic and phylogenetic analysis. These
groups are called virus genotypes.
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